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ABSTRACT 
 Single walled carbon nanotubes (SWNTs) are considered potential biomedical 
materials because of their flexible structure, hollow interior for fluidic transport, propensity 
for functionalization of the exterior walls, and biocompatibility. Research into exploiting 
these properties has focused on SWNTs as building blocks for novel drug-delivery systems, 
dosage forms, and biomedical substrates. However, the use of the internal nanochannels as 
conduits for trans-membrane drug delivery has not been explored. This research was initially 
designed to explore the latter.  
 It is postulated that due to their mechanical strength and the presence of an internal 
conduit, SWNTs can be used for nanofluidic transport. Using a magnetic field, the 
magnetically responsive SWNT are driven into intact stratum corneum, creating 
nanochannels, for trans-membrane drug delivery. Initial studies showed however that a 
bottleneck is the aggregation of SWNTs on the surface of stratum corneum. To achieve trans-
membrane nanofluidic delivery, the SWNTs have to be well dispersed in an appropriate 
pharmaceutical medium, and the SWNT have to be of high purity. Similarly, the presence of 
impurities in SWNTs, and the dispersion state of these materials in pharmaceutical solvents 
may give an insight into the discrepancies in toxicity that is reported. 
 The purity of five commercially available SWNTs (AP-SWNT and P2-SWNT, from 
Carbon Solutions Inc, HMS-SWNT from Helix Materials, and NA-SWNT from 
Nanostructured and Amorphous Materials Inc. and CT-SWNT from ChepTubes Inc.) were 
analyzed by raman and electron dispersive x-ray spectroscopy (EDS) spectroscopy. 
Secondly, the dispersion states of SWNTs in various pharmaceutical solvents were evaluated 
by ultraviolet (UV) spectroscopy, scanning electron microscopy (SEM), dynamic light 
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scattering (DLS), zeta potential, and Raman spectroscopy to identify potential agents for 
exfoliation of SWNTs in selected pharmaceutical solution. 
 SWNTs were dispersed in various solvents (water, propylene glycol [PG], 
dimethylsulfoxide [DMSO], and ethanol) as well as in 0.1% w/v aqueous solutions of 
anionic, cationic and neutral surfactants at a SWNT concentration of 0.1 mg/mL. SWNT 
suspensions described as dispersed yielded an evenly coloured suspension with no visible 
precipitate. The most stable dispersions were obtained with the gemini surfactants, which 
were confirmed by SEM observation of exfoliated SWNTs. Zeta (ξ) potential 
measurements of the fully dispersed SWNTs showed typical values of greater than +30 
mV, while non-dispersed samples were less than +20 mV. SEM images of the dispersed 
solution showed the presence of exfoliated SWNTs compared to the aggregated SWNT 
clusters observed in non-dispersed systems. Raman spectra of dispersed SWNTs showed 
G-band peak shifts (to higher wavelengths), confirming the presence of exfoliated 
SWNTs.  
 Even though the purity of SWNT did not correlate with amount of SWNT in 
dispersion, exfoliation of bundled SWNTs was accompanied by an increase in UV 
absorbance of the dispersion, with maximum exfoliation determined by a relatively stable 
UV absorbance.    
 As pharmaceutical excipients, we have demonstrated that gemini surfactants are 
suitable dispersing agents for SWNTs, and shown that the dispersion of SWNT for 
gemini surfactants (12-3-12) is achieved below the critical micelle concentration. The 
dispersion of SWNT bundles into individual strands is the first crucial step towards their 
use in biological systems as drug carriers.  
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 1
1.0 CARBON NANOTUBES AS PHARMACEUTICAL AND BIOMEDICAL 
MATERIALS  
 
1.1   CNTs in delivery of therapeutic agents 
 The applications of CNTs as drug excipients are of interest, given their capacity to interact 
with macromolecules such as proteins and DNA [1]. The salient characteristics of an efficient 
drug delivery system include its ability to perform controlled and targeted drug delivery, which 
CNTs have been shown to exhibit [2]. Three methods of interaction between CNTs and 
pharmaceutically active components are possible in drug delivery. The first method of 
interaction is as a porous absorbent for the entrapment of active components within a CNT mesh 
or CNT bundle (Figure1.1, A). The second is through functional attachment of the compound to 
the exterior walls of the CNTs (Figure 1.1, B). The third approach involves the use of CNT 
channels as nanocatheters (Figure 1.1, C).  
 Venkatesan et al. [3] used CNTs as a porous nanoparticulate absorbent in the controlled 
delivery of erythropoietin (EPO) in mice. The solubility of SWNTs was obtained by dispersing 
them in various surfactant solutions. An 11.5% increase in bioavailability of EPO in serum was 
demonstrated when EPO formulations contained CNTs, compared with formulations without 
CNTs. A more specific application of CNTs requires control at the nano-level, by attaching a 
drug to individual CNTs for drug delivery, rather than exploiting a bulk property of CNTs. The 
exohedral and potential endohedral attachment of pharmaceutically functional molecules is of 
interest. With exohedral binding, drug moieties are attached to the exterior of CNTs for 
subsequent delivery into cells. CNTs have a distinct outer surface that makes them amenable to 
functionalization. The diverse functional groups introduced onto the surface act as “linkers” to 
therapeutic moieties, for subsequent delivery into cells (Figure 1.1, B). 
 2
 
 
 
 
Figure 1.1  Schematic representation of (A) a bundle of CNTs as a porous matrix encapsulating drug molecules between the 
grooves of individual CNTs, (B) moieties attached to the exterior of a CNT either by covalent bonding to the CNT wall 
or by hydrophobic interaction of moieties with the CNT walls, and (C) the encapsulation of moieties within the internal 
nanochannel of a CNT. 
2
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 With endohedral delivery, nanoparticles (particles with at least one dimension <100 nm) 
are encapsulated and transported through the inner cavities of CNTs (Figure 1.1, C). This raises 
the prospect of controlled nanofluidic delivery of therapeutic agents.   
The application of CNTs as carriers is increased by their propensity to penetrate cells. 
Cationic functionalized CNTs (f-CNTs) can be bound to active molecules via stable covalent 
bonds or supramolecular assemblies based on electrostatic attractions. Two possibilities exist: (1) 
the more energetically feasible attachment onto the exterior either by covalent or non-covalent 
interactions, and (2) the encapsulation of these molecular assemblies within CNTs. 
Predominantly, reports on the use of CNTs in drug delivery have focused on the use of CNTs as 
carriers for large biomolecules. Tables 1.1 and 1.2 summarize the use of CNT-biomolecular 
conjugates in therapeutic delivery. 
  
1.1.2  Functionalization of carbon nanotubes for pharmaceutical applications 
 Several approaches have been developed to functionalize CNTs (f-CNTs). They include 
the functionalization of defective CNT sidewalls, covalent functionalization of intact CNTs 
(Table 1.1), and noncovalent functionalization or adsorption onto CNT sidewalls (Table 1.2). 
Covalent functionalization of CNTs using the versatile 1,3-dipolar cycloaddition mechanism is 
the most widely used approach to covalently attach molecular moieties to CNTs (Table 1.1, 
structures I-VII) for the delivery of therapeutic molecules. The resulting amine-terminated 
reactive CNT-intermediates are the reactive centers for subsequent attachment of functional 
moieties. This has become the general synthetic strategy, allowing for the easy preparation of a 
common intermediate with a reactive group, for subsequent functionalization to the desired 
compound. By this scheme, the attachment of an ammonium-terminated triethylene glycol chain 
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(reactive intermediate) to CNT sidewalls allows for the synthesis of several CNT-functionalized 
compounds (Table 1.1, structures I-VI).  
 F-CNTs used as vectors for in-vitro delivery of therapeutic levels of amphotericin B 
(AmB) [4] are obtained from the 1,3-dipolar cycloaddition reaction (Table 1.1, II). Even though 
AmB is a very potent and effective antibiotic for the treatment of chronic fungal infections, its 
use is limited because of its potential toxicity to mammalian cells. This toxicity is attributed, in 
part, to the formation of aggregates because of low solubility. To avoid these concerns, AmB can 
be conjugated to CNTs, which increases its solubility and results in decreased aggregation. The 
decrease in toxicity and increased antifungal activity of the CNT-AmB conjugate was 
demonstrated in Jurkat cells, and modulation of antibiotic activity against three types of fungi: 
Candida parapsilosis, C. albicans, and Cryptococcus neoformans [4]. 
 Chen et al. [5] obtained amine-terminated CNT conjugates via the derivatization of 
carboxylated CNTs with thionyl chloride (SOCl2), and subsequent reaction with octadecylamine, 
yielding a versatile intermediate. Besides 1,3-dipolar cycloaddition, Yinghuai et al. [6] employed 
nitrene cycloaddition to covalently bind carborane cages to CNTs [6] (Table 1.1, structure VII), 
resulting in improved aqueous solubility of these boron containing chemotherapy moieties; a 
prospect for improved targeted delivery into cancerous tumours. 
 Functionalization with polyethylene glycol (PEG) moieties (also termed PEGylation) has 
been widely used to improve the solubility of the CNT-conjugate in aqueous solutions, as well as 
the biocompatibility of the moieties [7-10]. Kam et al. [9] reported the hydrophobic interaction 
between CNT sidewalls and the hydrocarbon chain of the phospholipid (PLip) component of a 
(PLip)-polyethylene glycol (PEG) moiety, to obtain noncovalent functionalization of CNTs. The 
PEG chains were functionalized with terminal amine (PLip-PEG-NH2) and maleimide (PL-PEG-
 5
maleimide) groups, resulting in positive interaction with a polar aqueous solvent. The amine and 
maleimide terminal groups provide another functionalization site for biomolecules. The 
heterobifunctional cross-linker sulfosuccinimidyl 6-(3’-[2-pyridyldithio]-
propionamido)hexanoate (sulfo-LC-SPDP) was conjugated with the phospholipid, forming a 
thiol bond. Upon reacting with the thiol functional groups from biomolecules, a disulfide bond is 
formed (Table 1.2, III).  
 
1.1.3   Delivery of therapeutic proteins, peptides, and genes by CNTs 
 F-CNT-DNA and f-CNT-protein conjugates are adept at crossing the cell membrane and 
subsequently lodging in the nucleus [11, 12]. This makes them a potential vector for transporting 
proteins [9, 11, 13-19] and genes [12, 20-23] into the nucleus, where the payload is released. 
Proteins are known to adsorb spontaneously onto the sidewalls of carboxylic f-CNTs, creating 
protein-CNT conjugates [17]. However, the binding of proteins onto the sidewalls of CNTs is 
highly selective. In an experiment to determine the complement activation of CNTs in blood, 
Salvador-Morales et al. [13] determined that of the 35 proteins in the human complement system 
(a group of 35 defense cell-surface proteins that recognize and clear invading moieties), 
fibrinogen and apolipoproteins were the proteins that bound onto CNTs in significant amounts 
[13]. Protein delivery, however, has been mediated by both anionic and cationic f-CNTs. 
In a study of the uptake of CNT-protein conjugates, Kam et al. [17] investigated the transfection 
of HL60 and Jurkat cell lines with acid-purified CNT-streptavidin conjugates. A higher 
expression of the protein was observed for the CNT-streptavidin conjugate transfection, 
compared with the streptavidin-only transfection. To establish that proteins bind non-specifically 
to acid-purified CNTs and that the mechanism of CNT-protein uptake by cells occurs by 
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endocytosis, Kam et al. [16] investigated the uptake of several other proteins (Protein A, bovine 
serum albumin, and cytochrome c) into adherent and non-adherent cell lines (HeLa, NIH-3T3 
fibroblast, HL60, and Jurkats cells).   
 Gene silencing, the introduction of short interfering RNA (siRNA), is a quickly emerging 
approach to genetic intervention. Using the complex (-CONH2-(CH2)-NH3+Cl-), messenger 
telomerase reverse transcriptase (mTERT), siRNA was successfully attached to SWNTs without 
losing its conformation. The attached moiety was successfully delivered into the cell cytoplasm, 
resulting in the suppressed expression of the TERT gene [19]. Kam et al. [9] synthesized (Table 
1.2, III) a “smart” siRNA delivery system, by coupling SWNTs to siRNA, through an 
enzymatically cleavable disulfide bond. The transfection of this moiety with HeLa cells showed 
significantly increased RNA interference (RNAi) activity. The process of CNT-mediated 
gene/protein delivery in vitro is illustrated in Figure 1.2, A (pathway 1). 
 Cationic f-CNTs have been used as carriers to deliver genes. Unlike the non-specific 
binding of proteins onto f-CNTs, the binding of DNA to these f-CNTs is by the electrostatic 
interactions between the phosphate backbone of DNA and the cationic functional groups.  
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Table 1.1  Covalent binding of bioactive molecules to CNTs 
 
CNT properties 
Type Functional group or structure 
Bioactive molecule Study aim/results Dispersion 
solvent 
Refs. 
SWNT/ 
MWNT 
NH3
A
.Cl
 
 
I. Ammonium-terminated triethyl 
glycol 
i. pCMV-ß-gal 
plasmid 
 
 
ii. Mouse 
splenocyte 
 
 
 
iii. ODN CpGs 
 
 
iv. G family of 
proteins 
 i. Effect of  attached functional group 
on DNA compaction and subsequent 
transfection 
 
ii. Immunology; in-vivo study of the    
antigenicity, and immune response of  
FMDV peptide-CNT conjugate in 
Balb/c mice 
 
iii. Increased production of  
immunostimulatory CpG motifs in 
mouse splenocytes 
 
iv. CNT-bound peptides successfully 
transfected in human 3T6 and murine 
3T3 fibroblasts 
i. Aqueous  
 
 
 
ii. Aqueous 
 
 
 
 
iii. Aqueous 
 
 
 
iv. Aqueous 
 
i.[22] 
 
 
 
ii.[14] 
 
 
 
 
iii. [18] 
 
 
 
iv. [11] 
SWNT/ 
MWNT 
OHOH
OH
OH
OH
OH
O
O
O
H2N
HO
OH
O
O
OHHOH
N
O
A
 
II. Ammonium-terminated triethyl 
glycol  
Amphotericin B Transfection and increased antifungal 
activity demonstrated in Jurkat cells 
against three species of fungi: Candida 
parapsilosis, C. albicans, and 
Cryptococcus neoformans 
Aqueous    [4] 
SWN
T 
A
N
H
NH3
NH3
O
.Cl
.Cl  
III. Ammonium-terminated 
triethyl glycol  
i. ß-gal plasmid 
 
ii. pCMV-ß-gal 
plasmid 
 
i. Transfection efficiency increased with 
increasing charge ratio (f-CNT:DNA) 
 
ii. Effect of  attached functional group 
on DNA compaction and subsequent 
i. Aqueous 
 
 
ii. Aqueous 
i.[11] 
 
 
ii. [22] 
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 transfection  
SWN
T A
N
H
H
N
S
O
OH
O
HO O
 
IV. Functional group attached 
to CNT 
i. Streptavidin 
 
ii. ODN CpGs 
 
 
i. Gene delivery and cytotoxicity study 
 
ii. Increased production of  
immunostimulatory CpG motifs in 
mouse splenocytes 
i. Aqueous 
 
ii. Aqueous 
i. [12] 
 
ii. [18] 
SWN
T A
N
H
N
O O
O
S
Ac Cys FMDV
V. Triethylene glycol- coupled 
to a maleimido linker. 
Functional group attached to 
CNT. 
i. G-family of 
proteins  
 
ii. Peptides 
derived from VP1 
protein of FMDV 
i. Protein delivery in human 3T6 and 
murine 3T3 fibroblasts 
 
ii. Immunology; in-vivo study of the 
antigenicity, and immune response of 
FMDV peptide-CNT conjugate in Balb/c 
mice 
 
i. Aqueous  
 
 
ii. Aqueous 
 
 
 
i. [11]  
 
 
ii.[14] 
SWN
T 
HN
N
O
O
O
S
Ac Cys FMDV
N
H
N
O O
O S
Ac Cys FMDV
N
H
O
A
VI. N-terminal and side chain 
N-deprotected lysine; 
functional group attached to 
CNT 
Peptides derived 
from VP1 protein 
of FMDV 
 
 
Immunology; in-vivo study of the 
antigenicity and immune response of  
FMDV peptide-CNT conjugate in Balb/c 
mice 
Aqueous [14] 
 
 
 
 
8
 
8
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SWN
T 
B B
B
B
B
B B
B
B
B
R
N
H
 
VII. Carborane bound to SWNT 
None Cell targeting by selective recognition of 
EMT6 cell with potential use in boron 
neutron capture therapy 
Aqueous / 
DMSO 
[6] 
Structure VII is directly bound to CNT sidewall, whereas structures I-VI are attached to a moiety defined below. R represents an 
alkyl chain of variable length. 
N O OThe moiety represented by A in structures I-VI =
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Table 1.2  Non-covalent binding of bioactive molecules to CNTs 
 
CNT properties 
Type Functional group 
Bioactive molecule Study aim/results Dispersion solvent Ref. 
SWNT None Erythropoietin Controlled release of EPO Mixed in several 
component formulations
[3] 
SWNT I. PL-PEG  and PL-PEG-FA 
molecules  
Cys-DNA Selective tumor marking and 
subsequent NIR irradiation 
in HeLa cells 
PL-PEG surfactant [24] 
SWNT II. None Streptavidin protein 
A (SpA), bovine 
serum albumin, and 
cytochrome c 
Non-specific binding of 
proteins onto CNT sidewalls, 
and increased transfection of 
conjugates 
Aqueous [16] 
SWNT H
N S
O
N
H
O
PEG
S
X
 
III. PL-PEG-NH2 and PL-
PEG-maleimide 
siRNA 
 
 
 
Gene silencing (siRNA) 
obtained by relative ease of 
cleavage of disulfide bond 
PL-PEG surfactant [9] 
Aligned 
CNT 
None pEGFP-cI plasmid Increased transduction by  
magnetofection of Bal17 B-
lymphoma and B cells ex 
vivo 
Nanosperse AQ™ 
surfactant 
[23] 
 
 
1
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Figure 1.2  Conceptual diagrams of selected pharmaceutical and biomedical applications of CNTs. (A), The two approaches for 
in vitro delivery of pharmaceutically active moieties into cells via endocytosis. Pathway 1 exploits the propensity of 
cationic f-CNTs to penetrate cells and their ability to bind these moieties as carriers for delivery. Pathway 2 uses f-
CNTs for cell targeting by incorporating moieties that bind selectively to epitopes or receptors on cells. (B), The 
concept of hyperthermic cell destruction, either by irradiating “endocytosed” CNTs directly or by triggering a 
hyperthermic device within the endocytosed CNTs. (The latter example is shown.) In either case, specific cell 
destruction is achieved without harming surrounding cells. (C), The use of CNTs/aligned CNTs as templates, as 
signal transfer substrates, and as nonbiodegradable substrates for the growth and support of neurons. CNT templates 
have been demonstrated to promote the growth and extension of neural extensions, as illustrated by the extensive 
neurite branching that follows the contour of the CNT bundle. CNTs can conduct electricity, so a neural signal can be 
detected and recorded by placing a probe on a conducting CNT matrix. (D), Spearing of immobilized cells with 
nickel-embedded ferromagnetic CNTs under the influence of a rotating magnetic field. CNTs spear cells cultured on 
a coverslip. 
 
 
 
 
 
 
1
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 Pantarotto et al. [21] successfully transfected HeLa and CHO cell lines with a plasmid (β-
galactosidase encoded gene, β-gal), using ammonium f-CNTs as a vector (Table 1, II). As with 
most cationic DNA delivery vectors, the level of marker gene expression (transfection 
efficiency) seems to be related to the f-CNT:DNA charge ratio. Significantly higher gene 
expression was reported for a f-CNT:DNA charge ratio of 6:1 than with a charge ratio of 2:1. 
The efficiency of the delivery vector in plasmid transfection was confirmed by a 10-fold increase 
in gene expression levels compared with that achieved with DNA alone. The association of the 
cationic f-CNTs with plasmid DNA is explained as an electrostatic interaction between the 
anionic phosphate backbone of DNA and the cationic centers on the surface of the f-CNTs. 
Similar to other cationic molecules, such as cationic lipids, f-CNTs condense plasmid DNA for 
gene delivery [25, 26].  
 Having established that f-CNTs increase transfection [21] , Singh et al. [22]  evaluated 
the effect of CNT type and the attached functional group on transfection efficiency of pCMV-β-
gal in A549 cells. Three different cationic f-CNTs were evaluated (Table 1, I and II, lysine f-
CNTs) to determine the effect of different attached functional groups on gene expression. The 
findings indicated that even though both cationic f-CNTs condense DNA, the extent of 
condensation depended on charge (cation) density. These findings also suggested that the large 
surface area of f-CNTs resulted in more efficient pCMV-β-gal condensation. However, this did 
not result in higher gene expression of transfected A549 cells. What is yet to be established is the 
extent to which DNA condensation affects the release of the plasmid within the cell and 
subsequent gene expression.  
 So far, the approach to cellular uptake of CNT-plasmid conjugates has been to incubate 
cell cultures with the respective f-CNT-plasmid conjugates. Cai et al. [23]  reported the use of 
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CNTs to spear nanochannels into Bal 17 B-lymphoma and B cells ex vivo. Vertically aligned 
nanotubes grown by PECVD with ferromagnetic nickel particles embedded at the tips were used 
as carriers for enhanced green fluorescent protein (EGFP) coding plasmids, and were driven into 
cells membranes under the influence of a magnetic force, as shown in Figure 2, D. This 
technique resulted in a high transduction efficiency and viability after transduction. The 
approach not only delivers the plasmids in a relatively short time, but, by varying the magnetic 
field, it can also be used to tune the efficiency of spearing. The potential of magnetofection 
delivery includes a drastic lowering of vector dose since close to 100% of cells were reported to 
express EGFP protein [23].  
 At present, several in-vitro trials point to the potential of CNT-DNA/protein conjugates 
as delivery vectors. Nonetheless, several fundamental issues remain to be addressed in the use of 
CNTs as potential biological transporters. One such issue is the entry mechanism that regulates 
the cellular internalization of CNTs and their cargos. Kam et al. [12, 16] propose that SWNTs 
traverse the cellular membrane via endocytosis, whereas Pantarotto et al. [21] suggest a 
nonendocytotic mechanism that involves insertion and diffusion of nanotubes through the lipid 
bilayer of the cell membrane. The plasmid/protein uptake findings of Pantarotto and colleagues 
reveal a novel combination of properties attributable to soluble CNTs and establish the potential 
of these structures as components of advanced delivery systems for a variety of therapeutics, 
even though the preliminary comparative gene expression data for lipid:DNA and f-CNT:DNA 
delivery systems showed that their f-CNTs were less effective for in-vitro transfection than were 
lipid:DNA systems [21]. 
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1.1.4  Delivery of vaccines by CNTs  
 Efforts are ongoing to develop novel systems for the delivery of protective antigens. The 
basic idea of using CNTs in vaccine delivery entails linking an antigene to CNTs, without losing 
its conformation, thereby inducing an antibody response with the right specificity. However, it is 
equally important that the incorporated CNTs do not possess intrinsic immunogenicity and, 
hence, trigger an immune response. CNTs therefore act as templates, upon which chiral 
molecules are attached, which in turn act as centres for molecular recognition [13-15, 27, 28] 
(Figure 1.2, A, pathway 2). 
 Pantarotto et al. [15] reported the use of CNTs in eliciting an improved immune response. 
Peptides derived from VP1 protein of the foot-and-mouth-disease virus (FMDV) were coupled to 
SWNTs (Table 1, V and VI). Serum samples from inoculated (by injection with CNT conjugates) 
BALB/c mice were collected and analyzed by enzyme-linked immunosorbent assay (ELISA) for 
presence of anti-peptide antibodies. Peptide-CNT complexes were shown to elicit greater 
immune response against the peptides, with no detectable cross-reactivity to the CNTs, 
confirming the non-immunogenicity of the carrier. It was also observed that the CNT-protein 
complex enhanced the immune response when attached to an antigen, which strengthens the 
possibility of incorporating CNTs in vaccines. 
 Bianco et al. [18] demonstrated that the presence of cationic f-CNTs (Table 1.1, IV) in the 
delivery of synthetic oligodeoxynucleotides containing CpG motifs (ODN-CpGs) improve the 
immunostimulatory properties of ODN-CpGs in vitro. Synthetic oligonucleotides containing 
CpGs are reported to confer nonspecific protection against cellular pathogens and enhance 
antigen-specific immune responses. These properties have made them target candidates for 
incorporation in vaccines. To evaluate the immunostimulatory properties of CNTs, various ratios 
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of CNT-ODN CpG complexes were incubated with splenocytes. The efficiency of the process 
was measured by the amount of IL-6, a proinflammatory cytokine whose production is 
stimulated by ODN-CpG secretion in the supernatant of the culture. The results showed higher 
levels of IL-6 when f-CNTs were complexed to ODN-CpGs than when only ODN-CpGs were 
incubated with splenocytes. From the forgoing, f-CNTs could potentially be used as non-
replicating vectors for proteins, peptide antigens, and CpGs. 
 
1.1.5  CNTs for delivery and targeting of biophysical treatments 
 Several uses of CNT moieties have been reported for targeted delivery and subsequent 
treatment. These range from the use of f-CNTs in cell targeting and biologically triggered drug 
release control [9, 24, 28, 29], in hyperthermia (i.e., destruction of cancerous cells by local 
heating) [24], and as carriers of biomolecules for gene therapy and gene silencing [6, 19, 30].  
Because of the strong optical absorbance of CNTs and their propensity for endocytosis, they 
have become candidates for a method to hyperthermically destroy cancerous cells. 
 Functionalizing CNTs with recognizable epitopes results in endocytosis of f-CNTs by 
cancerous cells only. Subsequently, IR laser radiation is used to locally heat the endocytosed f-
CNTs, resulting in thermal destruction of cancer cells without harming surrounding healthy cells 
(Figure 1.1, B) [24]. This selective killing of cancerous cells that contain CNTs is attributed to 
the strong optical absorbance of SWNTs in this spectral window. Using this approach of 
selectively targeting tumor cells, Kam et al. [24] functionalized SWNTs with a phospholipid-
polyethylene glycol moiety (PL-PEG) and with folic acid (FA) collectively described as PL-
PEG-FA (Table 1.2, I). Transfection of the SWNT-(PL-PEG-FA) with HeLa cells expressing the 
folate epitope results in transfection, together with uptake of SWNTs. Hyperthermic treatment of 
 17
a mixture of healthy and folate-expressing tumor cells resulted in the death of only folate-
expressing cells. McDevitt et al. [28] developed a tumor targeting CNT construct by attaching 
the monoclonal antibodies Rituximab and Lintuzumab to the f-CNT (Table 1.1, I). To establish 
specific binding, these constructs were shown to specifically bind to Daudi (CD20+) and HL60 
(CD33+) cells, with no binding observed for HL60(CD20-) and Daudi (CD33-)  and  tumor cells 
to the exclusion of healthy cells. Using the high aspect ratio of the SWNT, several other 
moieties, such as fluorescent probes (GFP and Luciferace proteins), and radiometal-ion chelates  
[111In] were simultaneously bound to the f-CNT together with the antibodies for improved 
detection.  
 Yinghuai et al. [6] reported the potential of substituted carborane (a polyhedral cluster of 
carbon and boron atoms) f-CNTs as a new delivery system for an efficient boron neutron capture 
therapy (BNCT). BNCT is an experimental radiotherapeutic treatment of cancerous tumors that 
uses a neutron beam to interact with boron injected into the blood stream. The injected boron 
collects in tumor cells, which are later irradiated and killed by a neutron beam. Cell-specific 
uptake of the CNT-carborane complex was observed (Table 1.1, VII). Orally administered 
carborane f-CNTs in in-vivo experiments showed a concentration of carborane in tumor cells, to 
the exclusion of healthy cells, blood and other organs.  Using what appears to be a rather 
simplistic approach, Zhang et al. [29], successfully achieved the dual goal of selective uptake of 
CNT moieties via folic acid (for cell targeting) and controlled release of the payload 
(doxorubicin, anticancer drug), by using an intermediate of carboxylated CNTs linked to selected 
polysaccharide molecules as intermediates.  
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 In view of these results, f-CNTs represent a new, emerging class of nano-delivery system 
for targeting cancerous cells. It will be necessary, however, to further evaluate the metabolism, 
biodistribution, and clearance of the CNT conjugates. 
 
1.1.6  CNTs as matrices for compounds that stimulate neuronal growth  
 CNTs are also potential biocompatible materials that can serve a dual capacity: as a 
supportive matrix [31-37] and as a conduit for delivering electrical signals [31, 38-40] on which 
neurons can grow into a specific neural bundle or network, resulting in the formation of neuron-
CNT hybrids (Figure 1.2, C). 
 These capabilities allow CNTs to form scaffolds to guide neurite growth [23, 31-35, 38, 
41-43]. The growth of neurites during neuron development and regeneration is controlled by a 
highly motile structural specialization at the tip of the neurite called the growth cone. F-CNTs 
aid neurite growth by providing a platform for the growth cone to grasp onto rather than growth 
relying on physisorption alone [33]. 
 The growth of neurons on CNTs suggests that they are biocompatible. Additionally, it 
has been demonstrated that selective chemical modifications of the tips/walls of CNTs enhance 
and control neurite outgrowth and branching. Hu et al. [34] observed that the number of neurite 
growth cones, length of neurite outgrowths, and the degree of branching on positively charged 
polyethyleneimine f-CNT templates was significantly higher than on neutral or negatively 
charged CNT substrates. Similarly, enhanced neurite growth and branching was observed when 
CNTs were coated with a bioactive neuron growth enhancer (4-hydroxynonenal) [32]. Upon 
establishing that positively charged f-CNTs can potentially support and enhance neurite growth, 
Lovat et al. [31] and Zhang et al. [35] both suggested the use of positively charged and aligned 
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CNTs as a template, patterned guide to grow an elaborate, and controlled neuronal network. This 
concept of a patterned CNT array allows the control of a three-dimensional neuronal network, a 
prerequisite for signal transmission and, ultimately, regeneration [31, 34, 35]. 
 Several research groups have explored the possibility of using conducting CNTs for 
transmitting and receiving electrical signals to and from neurons. Wang et al. [39] developed a 
prototype neural interface based on a CNT microelectrode that is capable of transmitting current 
pulses to hippocampal neurons preloaded with Fluo-4 AM ester, which responded by increased 
fluorescence because of influx and binding of Ca2+ to the dye. Lovat et al. [31] also demonstrated 
an increase in spontaneous postsynaptic currents in hippocampal neurons grown on a CNT 
substrate even when the neurons were randomly spaced apart on the substrate, suggesting that 
electric coupling had occurred between neurons and the CNTs. Similarly, Liopo et al. [38] 
demonstrated the direct stimulation of NG108 neuroblastoma and rat dorsal root ganglion cells 
grown on a SWNT-polyethylene terephtalate film, by an electrode that was attached to the film 
at a remote site. Gabay et al. [40] have shown that electrical signals can be transmitted in the 
opposite direction as well. The CNT-multielectrode array, made up of 60-80 µm diameter CNT 
islands, not only transmitted electrical signals from rat cortical cells grown on its surface, but 
also transmitted signals that could be recorded with high sensitivity. 
 The multiple functions of CNTs, such as being a biocompatible substrate, and electrical 
signal conductor and carrier of neural growth-promoting substances on their surfaces or within 
their cavities, may be important in neural tissue regeneration and/or stimulation, leading to their 
use as implantable prosthetic templates for the growth and support of neurites. As CNTs are not 
biodegradable, these scaffolds can be useful as implants in cases where long-term extracellular 
molecular triggers for neurite outgrowth are required. They could therefore be employed as an 
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extracellular scaffold to guide directed neurite outgrowth, the potential use of which is desirable 
after spinal cord or brain injury [34].   
  
1.1.7   Encapsulation of molecules in CNTs 
 The unique enclosed nanochannels within CNTs make them potential nanofluidic 
delivery devices for pharmaceuticals, as well as protective structures for environmentally 
susceptible pharmaceuticals. Because of the size of CNTs and their propensity for cell 
entry/uptake, targeted delivery of CNT-ferried pharmaceuticals at the cellular level could be 
enhanced, and the discomfort associated with current intrusive techniques minimized.  
The first possible use of CNTs to protect therapeutic moieties is as structures to encapsulate the 
moiety within the CNTs. Shaitan et al. [44] modeled a non-immunogenic CNT nano-container, 
which encapsulated a bioactive peptide (pentadecapeptide and cholesterol) and an explosive 
agent. Once transplanted within a cell, an external trigger sets off the explosive agent, releasing 
the encapsulated peptide into the cytoplasm of the cell. Leonhardt et al. [45] proposed 
incorporating a ferromagnetic material, together with a therapeutic agent and a temperature 
sensor, into CNTs. This would allow for the manipulation of CNTs, using an external magnetic 
field and trigger, to destroy cancerous cells via hyperthermia. 
 The second possible use of CNTs is as structures for nanofluidic delivery of 
therapeutics. Table 1.3 summarizes studies of the type of pharmaceutically active 
molecule encapsulated, the diameter and type of CNT, and the conditions of 
encapsulation. One simple approach to fill nanotubes is to use capillarity forces [46-51]. 
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Table 1.3  Encapsulation of molecules in CNTs 
 
CNT Diameter of 
CNT 
Molecule/size of 
encapsulated entities 
Conditions of encapsulation Ref. 
MWNT 10-20 nm DNA 400K and 3 bar [51] 
SWNT 1-2 nm DNA “Plasma ion irradiation” of DNA electrolyte by 
applying direct current and radio frequency 
[52] 
SWNT 1.5 nm RNA Electrophoretic transport through cavity 
enhanced by changes in RNA conformations 
[53] 
MWNT 500 nm Fluorescent-labeled 
beads/50 nm 
Capillary inbibition of beads [46] 
 
 
 
 
 
 
 
 
 
2
1
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 However, to use the inner channels of CNTs for nanofluidic delivery, it is essential to 
understand capillary behavior at the nanoscale. First, the nanochannels must be sufficiently wet, 
i.e., have the ability for a liquid to spread along the walls of the nanotube. It is a direct reflection 
of the competitive cohesive forces within the liquid and the strength of interaction between the 
liquid and the CNT material [47, 48]. Second, surface tension of the filling fluid should be low 
enough to achieve wetting. For graphitic materials like CNTs, wetting is possible only if the 
surface tension at the fluid-CNT interface is less than a threshold value of 200 mN/m [47]. 
Beside the liquid wetting properties, certain structural properties of CNTs also influence 
capillarity. Molecular dynamics simulations and initial experimental results [47] both suggested 
that CNTs are hydrophobic. However, recent experimental results indicate that hydrothermal and 
CVD-synthesized CNTs are indeed hydrophilic, suggesting an increasing ease in wetting and 
hence capillarity. The efficiency of capillary imbibition was also established to be diameter 
dependent [54].  
 Cui et al. [51] reported the encapsulation of Pt-labeled DNA molecules in MWNTs (10-
20 nm internal diameter) as depicted in Figure 1.3, C. However, encapsulation was achieved 
under rather extreme conditions (400K and 3 bar), which might not be suitable for most 
pharmaceutical compounds (Table 1.3). Hence, a better approach to encapsulation, rather than 
improved capillary action, would be more suitable in this application. Kaneko et al. [52] reported 
the encapsulation of DNA by “plasma ion irradiation,” by applying direct current (DC) to an 
electrolytic solution of DNA in water. SWNTs were immobilized on the anode (aluminum 
support) and an applied DC drove the negatively charged DNA towards the anode. Encapsulation 
of DNA increased when a radio frequency field (RF) was simultaneously applied with the DC. 
The application of the RF changes the native random-coil structure of the DNA, to a stretched 
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form, thereby reducing its diameter. By compromising the nano-dimensions (i.e., increasing the 
diameter), 50-nm fluorescent-labeled polystyrene beads in ethylene glycol/water were 
encapsulated in 500-nm diameter CNTs by capillary action (Table 3) [46]. Using CNTs of 
similar dimensions, Nadarajan et al. [55] encapsulated 10-100 nm nanoparticles in a viscous 
solution by optimized centrifugation. However, nanofluidic delivery was greatly enhanced when 
a particulate driving mechanism was introduced. By using electrophoresis as a driving force, a 
charged nanoparticle (ssRNA) laden solution was shown to flow through 1.5-nm CNT 
nanochannels [53].  
 Measurements of the hydrophobicity of vertically aligned carbon nanotubes (VANTs) 
indicate that they are even more hydrophobic that individual CNTs [56], having been described 
as “superhydrophobic”. The implication of such a property is the increased difficulty in wetting 
VANTs. However, by electro-wetting their superhydrophobicity is significantly reduced, which 
allows for wetting and reduced surface tension at the water-CNT (solid/liquid) interface, 
improving capillary imbibition [57]. 
From the foregoing, it is envisioned that CVD- and hydrothermal-synthesized CNTs, with large 
enough diameters, should imbibe and subsequently maintain consistent nanofluidic delivery. 
Alternatively, the rather prohibitive superhydrophobicity exhibited by an array of CNTs can be 
overcome by electro-wetting and subsequent use of the numerous nanochannels for nanofluidic 
delivery. Fluid flow through CNTs has been demonstrated to be much faster (four to five orders 
of magnitude greater) than conventional estimates suggest [50].  
 A novel system could be designed to deliver charged therapeutic molecules using a nano-
dispensing system by taking advantage of diameter-selective encapsulation, coupled with 
electrophoresis and electro-wetting. 
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1.1.8  Toxicity of CNTs 
 Despite the widely demonstrated potential of CNTs in drug delivery, research indicates 
these particles can potentially cause adverse effects because of their small size and extreme 
aspect ratio(length-to-diameter ratio) [58]. The microscopic size and weight of CNTs allows for 
their easy distribution in the environment and human body. The general approach has been to 
consider and treat CNTs as toxic, since nano-sized particles are markedly more toxic than larger-
sized particles. However, controversy surrounds the interpretation ascribed to CNT toxicity data. 
What is apparent however, is that toxicity is related to properties of the CNT material, such as 
their structure (SWNT vs. MWNT), length and aspect ratio, surface area, degree of aggregation, 
extent of oxidation, surface topology, bound functional group(s), and method of manufacturing 
(which can leave catalyst residues and produce impurities). Toxicity of CNTs is also related to 
their concentration and the dose to which cells or organisms are exposed [59]. 
 
 
1.2      Parameters of quality; Purity and quality of dispersions  
 The prospects of carbon CNTs as excipients in drug delivery has gained currency, mainly 
because of the high aspect ratio, ease attaching bioactive functional moieties to the external 
sidewalls via functionalization [1, 18, 20, 60-63], propensity to penetrate into cells, and the 
presence of an inner cavity that can be exploited for controlled nano-fluidic delivery [59, 64].  
To this end, CNTs have been demonstrated as functional biomedical particles in for the in vivo 
delivery of proteins[11-18, 30, 63], DNA[16, 20-22, 65, 66]. The attachment of functional 
groups onto these biocompatible materials have allowed for their use centers of chiral 
recognition for the attachment of functional chiral moieties, which are subsequently used for 
molecular targeting [9, 24, 28, 66-68].  
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 Even with the ongoing research into new and improved CNT synthetic techniques; there 
has been little improvement in the control of CNT quality, controlled chirality and diameter. 
CNTs obtained from different synthetic methods have different physical properties. The quality, 
quantity, and type of nanotubes synthesized depend on the synthetic method used. For example, 
CNTs from an electric arc-discharge (EAD) source have a higher Young’s modulus and fewer 
defects than those from a CVD source. Hence, the choice of synthetic method is guided by the 
intended use of the CNTs. Invariably; the inherent reaction conditions will also have an effect on 
the product.  
 A major bottleneck bedeviling the CNT community is the lack of a standard for CNT 
quality analyses [69].  The disparity between reported purity of CNT (presence of CNT in 
sample) materials and those obtained from independent analyses [69, 70] , and those reported by 
the suppliers From commercial sources) has been a long standing problem. Typically, 
commercial CNT from vendors are accompanied by what is described as product information 
sheets, purported to contain the quality analysis of the accompanying material (Table A1, 
Appendix A). These typically consist of a Raman spectrum and an electron micrograph (either 
by SEM/TEM) with the accompanying elemental analysis. It is now common practice to 
advertise CNT as >95 % purity when in deed the sample contains >95 % carbon content and not 
nanotube content. Since it is well accepted that neither Raman spectroscopy, electron 
microscopy, nor elemental analysis can by themselves or in combination with the others state the 
purity of the CNT material, this raises fundamental questions; How are the stated purity levels 
quoted by the vendors obtained, can the quoted purity levels be re-produced, and what do the 
various terminology of percentage of CNT, percentage of carbon, weight purity, volume purity, 
carbon content etc. represent? 
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 Typically, excipient standards for pharmaceutical use are defined in the form of a 
monographs in the United States Pharmacopeia (USP) [71]. For excipients, the USP contains 
three major components; positive identification of the excipient, presence of impurities, and 
specialized assays [72]. The positive identification of the excipients pertains to a collation of 
both physical (boiling and melting points, dissolution, particle size, specific gravity, and 
chemical (molecular weight, chemical identifier) as well as organoleptic description (odour, 
colour etc). The monographs also include the identity of impurities (often residual starter 
materials in the synthesis). The tests also establish such parameters as the stability and 
dispersibility in routinely used pharmaceutical solvents. Often, a reference standard, with defined 
purity and impurity content, determined by standardized experimental procedures are established 
for purposes of calibration. Subsequent excipient samples/batches are evaluated against this 
standard.  
 However, with new pharmaceutical excipients such as CNTs, no such standards have 
been established yet. Despite the extensively reported use of CNTs in drug delivery research, and 
biomedical applications, the purity (quality) analysis has often been incomplete. It is therefore 
not surprising that contradictory reports have been published regarding the toxicity of pristine 
CNTs [73-77]. Lam et al. [74] ,Shvedova et al. [78] and Muller et al. [77] reported that CNTs 
possessed inherent toxicity whereas Warheit [76] et al. and Pulskamp et al [79] found otherwise. 
Pulskamp et al .[79], reported that oxidative stress due to the presence of remnant catalytic iron 
particles in the pristine SWNTs was responsible for the observed toxicity rather than an inherent 
property of the CNTs. Interestingly however, there appears to be a consensus that 
functionalization of CNTs with cationic moieties does improve their toxicity profile [80, 81].   
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Gao et al. [80] reported that toxicity of cationic f-CNTs is a function of CNT surface cation 
density. These observations indicate that soluble f-CNTs are biocompatible and exhibit a 
significantly improved toxicity profile than do pristine CNTs. The dichotomy in toxicity of 
pristine CNTs versus functionalized CNTs can be attributed to the size distribution of particles in 
the formulation. Pristine CNTs have a tendency to aggregate in aqueous solutions as a result of 
their hydrophobicity, resulting in increased cytotoxicity, whereas functionalization generally 
increases the solubility and hence dispersion of CNTs in solution, resulting in a reduced toxicity 
[81].   
 To the best of our knowledge, no CNT supplier has indicated a set of qualities that would 
make their nanotubes suitable for use as pharmaceutical excipients. For pharmaceutical 
applications, a set of parameters reflecting the purity, physical (diameter, length, chirality), 
chemical (surface defects, functional groups) properties and dispersion characteristics of CNTs, 
will have considerable impact on the biological fate of carbon nanotubes. A standard set of 
parameters and consistent protocols must be developed to evaluate these properties. Although 
various techniques have been used to characterize CNTs, there appears to be issues with 
reproducibility of the reported purity values. It is not surprising that the reported quality 
(percentage purity) of commercially available CNTs is contentious. The material safety data 
sheets that accompany CNT samples usually indicate the purity of CNTs (presumably obtained 
from qualitative electron microscopy techniques) and the diameter of material (estimated from 
Raman spectroscopy).  
 It would be ideal that CNT raw material for pharmaceutical applications have 
comparatively low carbonaceous impurities, and a more homogenous size and length 
distribution. Applying these criteria, CVD-synthesized CNTs would be the preferred choice of 
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synthetic method. However, removing the metallic catalyst residue is still required. CNT samples 
may contain a significant amount of other carbonaceous materials (graphite, amorphous carbon 
etc), as well as residual catalytic particles left over from the synthesis, and embedded within the 
CNT. To explore the use of CNTs in the pharmaceutical industry, high purity material is 
essential for pharmaceutical excipients. 
 
1.2.1   Structure and Properties of Carbon nanotubes 
 Carbon nanotubes belong to the fullerene family of carbon allotropes. They are 
cylindrical molecules consisting of a hexagonal arrangement of sp2-hybridized carbon atoms (C-
C distance of ~1.4 Å). They are described as hollow cylinders formed by rolling single or 
multiple layers of graphene sheets into seamless cylinders [82]. These cylindrical structures have 
two forms: single-walled carbon nanotubes (SWNTs) and multi-walled carbon nanotubes 
(MWNTs). SWNTs are comprised of a single cylindrical graphene layer capped at both ends in a 
hemispherical arrangement of carbon networks (Figure 1.3). The closure of the cylinder results 
from the inclusion of pentagonal and heptagonal C-C structures during the growth process. 
MWNTs comprise several to tens of concentric cylinders of graphitic shells, each one forming a 
SWNT. MWNTs generally have a larger outer diameter (2.5-100 nm) than SWNTs (0.6-2.4 nm) 
and consist of a varying number of concentric SWNT layers, with an interlayer separation of 
~0.34 nm. SWNTs have a better defined diameter, while MWNTs are more likely to have 
structural defects, resulting in a less stable nanostructure [83].
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Figure 1.3 Computer-generated images of carbon nanostructures using Nanotube Modeler© 2005 from JCrystalSoft, showing the 
structures of (A) cylindrical shape of a single-walled carbon nanotube (SWNT) that can be obtained from the  various 
orientation (conformations) of the graphene hexagons of (B) an armchair with chiral , (C) zig-zag, and (D) a chiral/helical.  
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 CNTs combine high stiffness with resilience and the ability to buckle and collapse 
reversibly. The high C-C bond stiffness of the hexagonal network produces an axial Young’s 
modulus (measure of the stiffness) of approximately 1 TPa and a tensile strength of 150 GPa 
[84], making CNTs one of the stiffest materials known, yet with the capacity to deform (buckle) 
elastically under compression [85].  
 SWNTs exist in a variety of structures, corresponding to the many ways a sheet of 
graphite can be rolled into a seamless tube (Figure 1.3 B-D)). This arrangement can make 
SWNTs behave as a well-defined metallic, semiconducting, or semi-metallic structure, 
depending on chirality and diameter. 
 The chirality of a SWNT is obtained from its chiral vector C which considers the 
arrangement of the graphite hexagons with respect to the SWNT axis and is completely defined 
by specifying a pair of two integer numbers (n,m) identifying the two components of C with 
respect to the lattice parameters of the graphene sheet. Examples of chiral vectors for the various 
configurations are defined along the illustrations in Figure 1.3. The armchair configuration has 
chiral vectors (n,n), are characterized by the perpendicular shape of the chair to the tube axis  as 
in Figure 1.3 B, whiles the zigzag conformation is characterized by vectors (n,0), and have a V 
shape perpendicular to the tube axis as in Figure 1.3 C. The remaining SWNT (i.e. neither 
armchair nor zigzag), are described as chiral or helical, as depicted in Figure 1.3 D.  
 1.2.1.1  Methods of production and expected quality issues  
 Since the discovery of CNTs [86], research into new and improved CNT synthetic 
techniques has been toward improved yield, better CNT quality, and controlled chirality and 
diameter. The major synthetic approaches include electric arc-discharge (EAD), catalytic 
chemical vapor deposition (CVD), and laser ablation (LA) [87].  
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 CNTs obtained from different synthetic methods have different physical properties. The 
quality, quantity, and type of nanotubes synthesized depend on the synthetic method used. For 
example, CNTs from an EAD source have a higher Young’s modulus and fewer defects than 
those from a CVD source. Hence, the choice of synthetic method is guided by the intended use 
of the CNTs. Invariably, the inherent reaction conditions will also have an effect on the product.  
In the EAD set-up, a plasmon is generated across carbon electrodes, resulting in the deposition of 
CNTs on a substrate. In its original configuration, the anode was constructed from pure graphite, 
resulting in MWNTs as the main product. However, the incorporation of nanometer-sized metal 
catalysts in the anode material yielded SWNTs. The limitations of EAD are its inability to 
produce either SWNTs or MWNTs to the exclusion of the other, control over CNT diameter, the 
rather tangled/bundled nature of the products, and the presence of metal impurities. This 
necessitates difficult and time-intensive purification stages by chemical and thermal treatment 
[87, 88]. 
 LA uses a laser beam to vaporize a graphite target mixed with a transition metal catalyst 
[89]. As with EAD, LA can yield both SWNTs and MWNTs. The introduction of a secondary 
laser improves the quality of CNTs by optimizing the vaporization of the target and minimizing 
the amount of carbon deposited as soot by the breakdown particles ablated by the primary laser 
[90]. The limitations of this technique are the narrow diameters of SWNTs produced, and the 
presence of tangled ropes and bundles along with graphitic particles, metals, and carbonaceous 
impurities.  
 Unlike LA and EAD, the feedstock in CVD synthesis is a vaporized hydrocarbon, 
typically mixed with an inert gas [91]. The feedstock is fed into a furnace where it decomposes, 
depositing CNTs onto a substrate. The substrate is prepared by embedding nanometer-sized 
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catalyst particles (e.g., nickel or cobalt) onto its surface [92, 93]. Various adaptations, such as 
plasma enhanced-CVD (PECVD) [94], thermal CVD (TCVD) [93], laser-assisted CVD 
(LACVD) [95], and high-pressure CVD (HiPco), have been made to the initial method [91]. 
CVD is currently the only method that allows for the direct synthesis and deposition of CNTs on 
patterned substrates and control of nanotube diameter [96].  
 Of the three synthetic approaches, CVD allows for more control over the morphology and 
structure of the produced nanotube, resulting in well-separated individual CNTs, either supported 
on flat substrates or suspended across trenches [97]. The length and diameter of CNT are 
controlled by the synthetic conditions. Whereas the length of both SWNT and MWNT (typically 
tens of microns) are controlled by the length of the synthetic time (the longer the time the longer 
the length), the diameter of SWNTs is controlled by the size of the catalyst, and typically 0.7-3.0 
nm wide. For larger sized catalyst particles, SWNT fail to grow, and instead the larger diameter 
MWNTs are formed [98].    
 It is imperative that CNT purity for pharmaceutical applications have comparatively low 
carbonaceous impurities, and a more homogenous size and length distribution. Applying these 
criteria, CVD-synthesized CNTs would be the obvious choice of synthetic method. However, 
removing the metallic catalyst residue is still required.  
 
1.2.2   Dispersion of CNTs in biocompatible media 
 The dispersion of carbon nanotubes (CNTs) in aqueous solvents is a pre-requisite for 
biocompatibility; hence the use of CNT composites in therapeutic delivery should meet this basic 
prerequisite. Similarly, it is important that such CNT dispersions be uniform and stable to obtain 
accurate concentration data. In this regard, the solubilization of pristine CNTs in aqueous 
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solvents remains an obstacle to the realization of their application potential, due to the rather 
hydrophobic nature of the graphene sidewalls, coupled with the strong π-π interactions between 
the individual tubes, causing the assembly to aggregate as bundles. 
The current carbon nanotube synthetic approaches yield CNTs, together with carbonaceous and 
metallic impurities, as tangled and aggregated clusters. These clusters are not discernible to the 
eye and are observable only via high magnification. This tangled and aggregated morphology is 
attributed to the rather strong π-π interactions between the individual tubes causing them to 
aggregate, and their high aspect ratio (ratio of length to diameter of individual CNTs) resulting in 
an entangled mass.    
 The most widely used approach to obtain individual and smaller bundle sizes of these 
materials has often been achieved by exploiting the solution chemistry to overcome the strong 
attractive forces (either by chemical of physical functionalization of the sidewalls). For 
biomedical and pharmaceutical purposes, the use of common excipients and solvents routinely 
used in pharmaceutical formulations is of interest. In the same vein, it is equally important that 
the resultant dispersions in pharmaceutical solvents and/or dispersions are characterized in terms 
of stability and size of CNT in dispersion. The size/aggregation state of the dispersions has a 
direct consequence on the toxicological profile of these nanomaterials [99-101].  
 Kim et al. [102] classified CNT dispersions into two categories; macro-dispersions 
consisting of “dissolved” CNT bundles in solution, and nanodispersions consisting of 
“dissolved”, exfoliated/individual  CNTs in solution. Several publications estimate the amount of 
individual CNTs in a dispersions by the statistical comparison of the fraction of CNTs with 
diameters within the defined range of CNT diameters as a function of the CNT concentration 
[103-106].  
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 To obtain CNT dispersions, four basic approaches have been used; covalent 
functionalization of CNT sidewalls, surfactant assisted dispersion, solvent dispersion and 
biomolecular dispersion [59].  
 
1.2.3  Dispersion of CNTs via covalent functionalization  
 The covalent functionalization of CNTs results in the attachment of a desired functional 
group onto the sidewalls and/or tips of CNTs, often resulting in a break in the π–electron 
network. The most common approaches to functionalization involves strong acid treatment 
(resulting in carboxylic/ hydroxyl functional moieties) [107], fluorination [108] and amine [22] 
treatment. Chemical functionalization of these kind result in the introduction of hydrophilic sites 
on the hitherto hydrophobic CNT surface.  
 Chemical functionalization is perhaps the most efficient form of obtaining well dispersed 
CNT in aqueous solution due to the presence of polar functional groups on the CNT surfaces 
[16]. However, functionalization of CNTs is invariably accompanied by shortening of the CNT 
lengths and damage to the sidewalls [109]. 
 Dispersion is achieved through the attenuation of the van der Waals forces between 
individual/bundles of CNT due to the introduction of functional groups on the surfaces. The most 
common functionalization approach is via carboxylation. In addition to improving the purity of 
CNT, carboxylation increases CNT dispersion by reducing the van der Waals forces between 
individual tubes, and bundles. However, the oxidation by acids introduces defects on the CNT 
walls (i.e. by disrupting the seamless graphene network), shortens the length of tubes, and 
invariably changes the intrinsic chemistry of the CNT.  
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1.2.4   Dispersion of CNTs via non-covalent methods 
 However, for the incorporation of CNT in pharmaceutical formulations, it is not only 
essential that these materials be exfoliated into individual CNT entities; the relative 
concentration of the exfoliated individual entities should be known. Table 1.4 below is a 
summary of the quantitative values reported for pristine CNT (i.e. this does not include 
pretreated acid purified/functionalized CNTs) dispersed in various solvents [104, 110, 111], 
surfactants [106, 112-122], and polymers [118, 122, 123]. The most common and frequently 
used dispersants for CNTs are surfactants. Of these, the anionic surfactants sodium dodecyl 
sulfate (SDS) [112-118, 122] and sodium dodecylbenzene sulfate (SDBS) [106, 113, 114, 117, 
118, 122] are the most frequently used. Table 1.4 contains a summary of the quantitative 
dispersions of CNT in relevant pharmaceutical solvents/excipients.   
 Islam et al [124] were the first group to investigate the effect of surfactant type and 
concentration on the yield of exfoliated SWNTs. Dispersions were deemed suitable when no 
visible aggregates were observed. Of the surfactants investigated, only SDBS, SDS and Triton 
X-100 (polyethylene glycol p-(1,1,3,3-tetramethylbutyl)-phenyl ether)) showed dispersion of 
SWNTs at concentrations above 0.1 mg/mL. Using the height of particles in an AFM 
micrograph, the population of exfoliated SWNTs for SDBS, SDS and Triton X-100 were 74, 16 
and 36 % respectively. The superior dispersing ability of SDBS and Triton X-100 to SDS is 
attributed to the presence of an aromatic moiety in its structure resulting in increased interaction 
with the graphitic SWNT surface. Similarly, SDBS disperses SWNT better that Triton X-100 
due the presence of a longer alkyl chain (12 compared to 8), and a smaller headgroup. Shin et al. 
[112] investigated the effect of the chemical structure of surfactants (neutral, anionic and 
cationic) and concentration on the dispersion of SWNTs. They established optimum surfactant 
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concentrations for 0.04 mg/mL concentration of SWNT. The optimized surfactant concentration 
was established by qualitatively examining TEM micrographs, coupled with the presence of 
characteristic Van Hove transitions in the optical absorbance spectra due to the metallic and 
semiconducting SWNTs. The optimized surfactant concentrations of all surfactants were slightly 
greater than their respective critical micelle concentration (CMC) values, suggesting SWNT 
stabilization through the formation of hemimicelles structures, covering the surface of the 
SWNTs [118, 125]. The stability of dispersions is attributed to the strength of interaction of the 
surfactant with the graphitic surface of the SWNT, the length of alkyl chain in the surfactant, the 
head group size, and charge. Thus, the presence of an aromatic ring as in IGP (polyoxyethylene 
(100) nonylphenyl ether) results in the structure of the surfactant produces a superior dispersion, 
compared with an alkyl chain (SDS and CTAB). Similarly, the CTAB has a lower optimized 
concentration than SDS due to the presence of a longer alkyl chain. Sun et al. [113] studied the 
optimized surfactant concentration required to disperse 10 mg/mL SWNT (Table 1.4), by 
measuring the fraction of CNT remaining after centrifugation for a wide concentration range for 
each of the selected surfactants. Contrary to the previous findings [112], the optimized surfactant 
concentration in all cases was found to be close to 10 mg/mL. It is therefore not yet certain if the 
optimized concentration of surfactant for CNT dispersion is a function of concentration, 
surfactant type, or even CNT type.  
 Yoon et al. [115]  developed a multi-step SWNT dispersion method which involves 
several centrifugation and steps (at different speeds). The extent of SWNT exfoliation was 
monitored by the intensity of a specific radial breathing mode (RBM) peak; while quantification 
of exfoliated SWNTs was by fluorescence spectroscopy.  
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 Yurekli et al. [116] investigated the mechanism of SDS absorption onto SWNT surfaces 
using small angle neutron scattering (SANS). Their investigation suggested a structureless 
interaction since the SANS data neither pointed to the cylindrical micelle structure proposed , not 
the wormlike model proposed [112, 124].  
 Coleman’s research group [106, 110, 111] have investigated the population/fraction of 
exfoliated SWNTs as determined by analyzing several frames of AFM images of SWNT 
dispersions. The major finding of this group is that ultracentrifugation is not required to obtain 
exfoliated SWNTs, and secondly, at the optimized sonication condition, the percentage of 
exfoliated SWNTs is a function of concentration. 
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Table 1.4  CNT dispersion, solubilization, debundling and stabilization by selected agents 
 
CNT type Dispersing Agent(s) Solubility Comment Reference 
SWNT 
(HiPCO) 
SDS 
IGP*1  
CTAB*2  
 
0.0.87mM CO-990 in 0.12 mg/mL 
SWNT, 1.51 mM CTAB in 0.08 
mg/mL SWNT, and 9.00 mM SDS in 
0.16 mg/mL SWNT 
Optimization of surfactant 
concentration and mass 
percent conversion of SWNT 
[112] 
SWNT 
(HiPCO)  
SDBS, SDS, LDS*3, 
TTAB*4 
SC*5 
Optimized dispersions were obtained 
close to 10 mg/mL for all surfactants 
(1 mg/mL SWNT) 
Statistical analysis of AFM 
micrographs  to determine 
the aggregation state of each 
dispersion 
[113] 
SWNT 
(HiPCO) 
 
SDBS, NaOBS, sodium 
benzoate SDS, sodium 
butylbenzene sulfonate, 
Triton X-100, DTAB*6; 
dextrin, PS-PEO  
Maximum dispersion for SWNT; 
SDBS (20 mg/mL), SDS (0.5 mg/mL), 
Triton X-100 (0.8 mg/mL), All others 
less than 0.1 mg/mL  
Determination of suitable 
surfactant: SWNT 
concentration ratios. Stability 
established by visual 
monitoring. 
[124] 
SWNT 
(HiPCO)  
SDS Maximum concentration of 26 mg/L 
(≡ 0.026 mg/mL) SWNT in 1 w/v % 
SDS.  
Qualitative and quantitative 
exfoliation monitored by 267 
cm-1 RBM peak intensity. 
and statistical analysis of 
AFM micrographs 
respectively.  
[115] 
SWNT 
(HiPCO)  
SDS (in D2O ) at 0.1, 0.25 
and 0.5 w/v % 
7 mg/L (=0.7mg/100mL) 
9 mg/L, 12 mg/L 
Qualitative study of SDS-
SWNT binding.  
[116] 
Purified 
SWNTs 
(HiPCO) 
 
SDBS (5 mg/mL) 10 % mass dispersion at 0.06 mg/mL 
nominal dispersion 
Max. partial conc. of 
individuals of ~0.006 mg/mL 
at a total concentration of 
~0.07 mg/mL 
[106] 
SWNT Encapsulation in 
poly(styrene)-block-
polyacrylic acid copolymer 
0.5g/L (0.05 g/100 mL= wt%) 
For polymer concentrations of 1- 10-4 
mg/mL 
Established by UV spec., 
using the Є500 = 2.86 X10-14 
g/cm2 
[123] 
SWNT N-methyl-2-pyrrolidone 0.02 mg/mL (=2mg or 0.002g/100 
mL) i.e. below this conc. No 
Fraction of dispersed SWNT 
obtained from the ratio of 
[104] 
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aggregates observed. At 0.004 mg/mL 
70 % of all dispersed particles are 
individual nanotubes) 
absorbance (650 nm) before 
and after centrifugation. 
SWNT 
(HiPCO)  
The max. ratio (of 0.1 
mg/mL SWNT :Surfactant) 
SDBS (1:10), SDS (1:10) 
SC*5 (1:100), CTAT (1:1), 
CTAB*2 (1:5) 
Weight of SWNT (mg) in supernatant; 
SDBS (0.065), SDS (0.045), SC 
(0.025), CTAB (0.04), CTAT (0.04) 
Quantification by UV, TGA. 
The subtraction method 
accounts for the non-
dispersed impurity 
component of the SWNT  
[117] 
SWNT γ-butyrolactone 0.004 mg/mL Fraction of dispersed SWNT 
obtained from the ratio of  
absorbance (660 nm) before 
and after centrifugation 
[110] 
SWNT 
(HiPCO ) 
Anionic surfactants: SDS, 
SDSA, SDBS, Sarkosyl, 
TREM, PSS-70. Non ionic 
surfactants: Pluronic® 
surfactants (P103, P104, 
P105, F108, F98, F68, 
F127, F87, F77, F85), Brij 
78 and 700, Tween 85, 
Triton X-405, and PVP-
1300 
Cationic surfactants: 
CTAB*2, DTAB*6 
Mass percent conversions of SDS (3.3 
%), SDBS (3.9 %), SDSA (6.0 %), 
Sarkosyl (2.8 %) TREM  (4.0 %), 
PSS-70 (4.7 %), P 103 ( 1.9 %), P 104 
( 3.0 %), P 105 ( 4.8 %), F 108 ( 8.7 
%), F 98 ( 9.4 %) , F 68 (5.8 %), F 127 
(7.1%) , F 87 ( 8.8 %) , F 77 (2.5 %), 
F 85 (0 %), Brij 78 (4.3 %), Brij 700 
(6.4 %), Tween 85 (3.9 %), Triton X-
405 (5.0 %), PVP-1300 (4.1 %) CTAB 
(5.1 %) DTAB (5.6 %) 
0.3 mg/mL SWNTs in 200 
mL of aqueous surfactant or 
polymer (2 wt %).  
[118] 
SWNT 
(HiPCO) 
Triton X-100 in D20 Optimized dispersion at 0.1 mg 
SWNT in 0.5-1.0 % w/v (dispersed in 
D2O) 
SANS study of optimized 
surfactant concentration for 
dispersion. 
[119]  
MWNT 
(Shenzhen 
Nanotech Port 
Co. Ltd., 
China) 
DTAB*6 
Hexyl-α,β,-
bis(dodecyldimethylammo
nium bromide) 
(C12C6C12Br2) 
Maximum dispersion for 2 mg/mL 
MWNT obtained at 2 and 30 mM for 
C12C6C12Br2 and DTAB respectively. 
surfactant structure on the 
stability of carbon nanotubes 
in aqueous solution 
[126] 
MWNT Pluronic F127 *7 180 μg/mL MWNT in 0.1 % Pluronic Pretreatment by stirring at 70 [121] 
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(Nanothinx, 
Greece) 
F127 from an [MWNT] of 0.5 mg/mL 
i.e. 36 % dispersion. 
oC before sonication. 
Concentration determined by 
UV spectroscopy 
SWNT 
(HiPCO) 
hvimBr*8, SDBS, SDS, 
CTAB 
The optimized surfactant:SWNT ratio, 
and the respective dispersion are: 
SDS; (10:1) at 45%, SDBS (13:1) at 
79 %, CTAB; (5:1) at 40 %, and 
hvimBr; (13:1) at 99 %. 
Investigate the use of long 
chain ionic liquid for 
dispersion 
 [122] 
*1- Polyoxyethylene (100)  nonylphenyl ether       
*2 -Cetyltrimethylammonium bromide 
*3-  Lithium dodecyl sulfate   
*4 - Tetradecyl trimethyl ammonium bromide  
*5 - Sodium Cholate    
*6 - Dodecyltrimethylammonium bromide 
*7 - Polyoxyethylene-polyoxypropylene block copolymer 
*8 - 1-hexadecyl-3-vinylimidazolium bromide 
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 1.2.4.1  Dispersion of CNTs via solvents 
 The most common approach to CNT processing requires its dispersion in a liquid 
medium [111]. However, due to the unique physicochemical properties of “as produced” CNTs 
such as high aspect ratio, bundled nature, and strong van der Waal’s forces between individual 
tubes, the choice of a solvent, capable of debundling (breaking up aggregate tubes into individual 
tubes) the tubes has been under investigation. The most promising group of solvents for CNT 
dispersion are the amide containing solvents [111, 127-129]. 
 Several authors attribute the ease of dispersion to the basicity (availability of a free 
electron pair) of the solvent, a low hydrogen bond donation parameter and a high solvatochromic 
parameter [127, 130], it has become evident that solvents such as dimethylsulfoxide (DMSO), 
which meet both of these parameters, have a rather low dispersion efficiency [129]. It is 
nonetheless agreed that even though these two parameters are a pre-requisite to the dispersion, 
they are by no means the sole contributors to dispersion. 
In their investigation on the effect of electron pair donicity (β) of organic solvents in the 
production of stable nanodispersions of CNTs,  Ausman et al.[127] concluded the presence of 
Lewis basicity (i.e. ability to donate a free electron pair) was the single most influential 
parameter in the production of a stable CNT dispersion. Consequently, the reported order of 
dispersion efficiency as determined by the optical density of the resultant dispersions was N,N-
dimethylformamide (DMF)> N-methyl-2-pyrrolidone (NMP)> hexamethylphosphoramide> 
cyclopentanone > tetramethylene sulfoxide>caprolactone (oxypanone). The presence of a lone 
pair of electrons on the nitrogen of the amides (i.e. increasing the basicity) appears to aid the 
dispersion, while the less available lone pair of electrons on the oxygen atom of the ketones 
reduces their dispersion efficiency.   
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 Landi et al. [129] studied the effect of amide solvent structure on their dispersion 
efficiency for five alkyl amide solvents; NMP, N,N-dimethylpropanamide (DMA), N,N-
dimethylpropanamide (DMP), N,N-diethylacetamide (DEA) and DMF. The dispersions were 
prepared from 0.1 mg/mL stock solutions prepared by sonication at 38.5-40.5 kHz for 30 min at 
40 oC, from which desired concentrations were obtained by serial dilution. Prior to determining 
the optical absorbance, each sample was centrifuged at 5000 rpm for 10 min prior to 
measurements. It was concluded that the dispersion was improved by increased CNT purity, 
optimized solvent geometry due to increased π-stacking (i.e. increased π-orbital overlap between 
amides and CNT sidewalls).  
 It was reported that the order of increasing dispersion efficiency DMA>DMP>DEA> 
DMF>NMP was attributed not just to the presence of a lone electron pairs, but an optimized 
geometry (bond lengths and bond angles) [129]. The maximum dispersion limit for these amide 
solvents as determined, using Beer’s plots based on the presence of sediments after 
centrifugation,  were DMF (1.56 μg/mL), DMA (6.25 μg/mL), DEA (3.13 μg/mL), DMP (3.13 
μg/mL).  
 1.2.4.2   Surfactant dispersion of CNTs  
 Surfactants in general can be useful for dispersing CNTs, although the chemical structure 
of the surfactant is important. Moore et al. [131] and Ham et al. [130] have independently shown 
that the dispersibility by nonionic surfactants is a function of the hydrophobic alkyl chain length 
of the surfactant. Ham et al. [130] determined that if adequate dispersibility is to be achieved, an 
alkyl chain length greater than C10 was required, and that dispersibility increased with 
increasing alkyl chain length [130]. Moore et al. [131] determined that within a series of 
nonionic Pluronic® surfactants (P103, P104, P105, F108, F98, F68, F127, F87, F77, F85), 
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solubility (i.e. measured by UV spectroscopy of individually dispersed CNTs) generally 
increased with increasing molecular mass. The highest efficiency of solubilization was achieved 
with Pluronic® F108 (MW: 14,600) and F98 (MW: 13,000), where solubilities of 8.7 and 9.4 
mg/L, respectively, were measured. These solubility levels were higher than those achieved by 
the other surfactants examined (Brij 78 and 700, Tween 85, Triton X-405, and PVP-1300). The 
higher molecular weight surfactants and polymers increased the solubility of CNTs through 
steric stabilization by adsorbed surfactant/polymer onto the walls of the CNTs, thereby impeding 
aggregation [132]. For ionic surfactant dispersion, Vaisman et al. [133] determined that the 
controlling factor for dispersion appears to be the charge of the head group, rather than the 
hydrophobic alkyl chain length.  
 The current limitations of surfactant-based solubilization are the relatively low levels of 
solubility and that the surfactant often remains as an impurity in downstream processes [133]. 
Nevertheless, this approach could be potentially useful in pharmaceutical applications, where 
surfactants are routinely incorporated in formulations for improved delivery.  
 
1.2.5    Analytical techniques for characterizing CNT parameters of quality and dispersions 
 For pharmaceutical applications, a consistent protocol must be developed to evaluate the 
purity, dispersion, and physical and functional properties of CNTs. These properties include 
nanotube size and type, surface defects, electronic characteristics, mechanical strength, and 
thermal conductivity. Although various techniques have been used to characterize CNTs, there is 
no industry standard to evaluate the quality of produced CNTs. It is not surprising that the 
reported quality (percentage purity) of commercially available CNTs is contentious. The material 
safety data sheets that accompany CNT samples usually indicate the purity of CNTs (presumably 
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obtained from qualitative electron microscopy techniques) and the diameter of material 
(estimated from Raman spectroscopy).  
 Several techniques have been used to characterize the structure and morphology of 
CNTs, to determine the purity of CNT materials, and to establish the presence or absence of 
exogenously bound moieties onto the walls of CNTs. The most extensively used techniques are 
thermogravimetric analysis (TGA) [69, 134], scanning electron microscopy (SEM) [69, 135], 
transmission electron microscopy (TEM) [15, 46, 136], atomic force microscopy (AFM), Raman 
spectroscopy [69, 107, 137-139], infrared (IR) spectroscopy [69, 140], and nuclear magnetic 
resonance (NMR) [15, 141-143]. Whereas TEM, SEM, and AFM have been used predominantly 
to qualitatively establish the general morphology of CNTs, IR spectroscopy, Raman 
spectroscopy, and NMR have been used to confirm the presence of functional groups on CNTs. 
Each technique has advantages and disadvantages for purity evaluation and each is 
complementary to the others.  
 1.2.5.1   Purity by electron microscopy and energy dispersive X-ray   
 spectroscopy 
 Transmission and scanning electron microscopy, are used in the preliminary evaluation of 
CNT morphology [69, 85]. It can be used as a qualitative confirmation for the presence of CNT, 
and carbonaceous material in the “as-produced” CNTs. These techniques are also used to 
evaluate the quality of CNT dispersions (extent of exfoliation into individual/small bundle sizes) 
[85]. The limitation of the EM imaging as a representative of the dispersion state is that the dried 
sample on a substrate is not representative of the dispersed state. 
 This technique is limited, however, by its inability to differentiate catalyst and 
carbonaceous impurities from CNTs [69]. However, coupled to an energy dispersive X-ray 
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spectroscopy (EDX/EDS), it is principally a qualitative tool for the elemental analysis of a 
sample. Another variation of this technique that could be employed for CNT analysis is the 
wavelength-dispersive x-ray analysis (WDX). This is often used in conjunction with SEM [144] 
and TEM for the morphological mapping of CNT surfaces (i.e. by SEM/TEM), and qualitative 
confirmation of the identity and location of residual catalysts in a CNT sample [144-154].  
These techniques utilize the characteristic x-rays generated when a sample is bombarded with 
electrons, to identify the constituents of a sample. The peaks in the resultant spectrum are 
specific to certain x-ray lines, allowing for the identification of the constituent elements in a 
sample.  
 EDX/WDA will be used to identify the residual catalysts materials in each CNT sample. 
This is important as the presence of residual ferromagnetic particles in CNT samples, could 
significantly affect their magnetic susceptibility.  
 1.2.5.2  Purity of CNTs by thermogravimetric analysis  
 As produced CNT samples are often accompanied by significant amounts of other carbon 
allotropes (graphite, soot, spherical fullerenes), and residual catalytic impurities. TGA relies on 
the differences in oxidative temperature of the various allotropes of carbon, and the catalytic 
impurities, to establish a definitive quantitative amount of either CNT type [69].  
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 However, significant variations in TGA traces, from samples of the same batch suggest a 
wide variation and difficulty in obtaining reproducibility. Even though this has been attributed to 
CNT heterogeneity, a relatively high number of repeats (>3), each requiring a significant amount 
of CNT material (~20-100 mg) will be required to establish a representative purity values. 
 1.2.5.3   Purity and dispersion quality by Raman spectroscopy 
 Raman spectroscopy has been used to evaluate the synthesis and purification processes of 
SWNTs. Carbonaceous impurities (graphite, spherical fullerenes, amorphous carbon, etc.) 
present a major obstacle in interpreting Raman spectra of SWNTs, as these impurities have 
characteristic Raman features (D- and G-bands) identical to that of SWNTs. A typical Raman 
spectrum of SWNTs has three intense bands. The low-energy vibrational band (100–400 cm-1) 
results from the radial movement of carbon atoms, resulting in the expansion and contraction of 
SWNT diameter [137, 138], hence the name radial breathing mode (RBM). For SWNT samples 
from an identical source, the frequency of the RBM peak is inversely proportional to tube 
diameter. Typically, the RBM and electron microscopy data are complementary in determining 
tube diameter. As only the Raman spectra of SWNTs show the RBM peak, the presence of such 
can be used to distinguish SWNT samples from all other carbonaceous materials. 
 The mid-energy vibrational band (D-band, ~1300-1400 cm-1) is a disorder-induced band, 
characteristic to all graphitic material. In SWNT samples, it is indicative of both the presence of 
defective sites on the SWNT (including functional attachments) and carbonaceous impurities. 
Similarly, the presence of functional groups on the walls of the SWNT is inferred from the D-
band [137]. The third band (G-band, ~1500-1600 cm-1) is a tangential vibrational mode, 
characteristic to all graphitic material. The ratio of intensities of the D-band (ID) to G-band (IG) is 
often used as an estimate of carbonaceous-impurity content and defect-site density [139]. Raman 
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spectroscopy is the most widely used tool in characterizing SWNT quality, even though it is 
unable to detect metallic impurities in a sample. It is often used as a complementary technique to 
electron microscopy.  
 A shift in peak position is generally observed for both the RBM and the G-band when 
CNTs disperse. The binding of the dispersing agent to the CNT results in an increase in the 
elastic constant of the harmonic oscillator of the coated CNT, thus increasing the energy required 
for vibration to occur, and thus an upward shift in the frequency of the band.  One distinguishing 
difference between a covalently attachment, and a non-covalently attachment, is in the intensity 
ratio of the D band (ID) and the G band (IG). Generally, a shift in peak is indicative of an 
interactive force between the dispersing agent, and the SWNT. However, shifts in peaks are also 
accompanied by a simultaneous decrease in D band intensity (ID) and an increase in G band 
intensity (IG). Covalent modifications to the sidewalls are characterized by a significant change 
in the D band and IG/ID ratio compared to the values obtained from pristine SWNT from the 
same batch [109, 155, 156]. 
 1.2.5.4  Dispersion quality by light microscopy  
 This is the first technique in qualitatively evaluating dispersion quality. It enables the 
qualitative determination of the degree of macro-dispersion under an optical microscope. The 
presence of visible precipitates will be an indicator of non-dispersion. This will be used to 
evaluate the efficiency of the centrifugation method. However, the presence and or extent of 
smaller sizes aggregates in the nano-range (<200 nm) can not be established by this technique.  
 1.2.5.5  Dispersion quality by particle size and zeta potential 
 The length distribution of nanotubes in solution has been measured within hydrodynamic 
approximations by using dynamic and static laser light scattering (DLS/SLS) [109, 157-160]. 
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DLS provides information for length distribution, whereas electrophoretic light scattering (ELS) 
generates the zeta potential, which provides information for the stability of ionic surfactant aided 
dispersions [85, 109, 159, 161]. 
 Zeta potential measurements of nano-dispersions are based on the well known Derjaguin-
Landau-Verwey-Overbeek (DLVO) theory. The DLVO theory states that the stability of a 
colloidal system is determined by the sum of these van der Waals attractive and electrical double 
layer repulsive forces that exist between particles as they approach each other due to the 
Brownian motion. It is postulated that the adsorption of ionic surfactants onto CNTs imparts a 
net charge on the surfactant-CNT composite. Consequently, a more diffuse layer of surfactant 
counter ions engulfs the composite, resulting in an electrical double layer, thus leading to 
colloidal stabilization via electrostatic repulsion. 
 In a CNT-surfactant composite, the mechanism of stabilization will be by steric repulsion 
(surfactant absorbed onto the surface of the CNT and preventing the individual CNTs coming 
into close contact). The use of DLS for the estimation of size for non-spherical particles is not 
necessarily valid due to the hydrodynamic approximations introduced. However, in combination 
with zeta potential measurements, the nano-/micro-dispersion sizes (measure over time), will 
explain stability i.e. as particles aggregate, the mass of the aggregates increase, resulting in 
slower movement and hence smaller zeta potential, whereas the presence of sufficient charge, 
particles tend to repel each other, preventing aggregation, and hence larger zeta potential [159]. 
 1.2.5.6        Dispersion quality by ultraviolet (UV) and photoluminescence spectroscopy  
 Dispersed CNTs are UV active because of their conjugated systems. Their concentration 
in solution, therefore, can be determined by Beer’s law, where a higher absorbance is obtained 
for dispersed CNTs in a solution than for an equivalent non-dispersed solution. In larger clusters 
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(bundles) of CNTs, however, the apparent absorption coefficients tend to decrease because of the 
similarity in size of CNTs to the wavelength of light [162, 163]. This has been used to evaluate 
the dispersion efficiency of various dispersing agents and conditions [130, 162-164], CNT 
dispersion stability over time [130], and the effect of SWNT diameter on dispersion [165]. The 
UV absorbance of the dispersion increases as exfoliation of bundles into individual tubes 
progresses, reaching a constant maximum value as the exfoliation process attains an equilibrium 
[132]. 
 The use of photoluminescence (PL) spectroscopy in determining the amount of 
exfoliation into individual CNT robes relies on the distinct difference in the amount of PL of 
single tubes (isolated tubes), and aggregated bundles [166-169]. Semiconducting SWNTs, which 
statistically constitute 66.7 % of any SWNT sample, are direct bandgap semiconductors and 
hence photoluminescence arising from the recombination of electron-hole pairs is expected [168, 
170].  The presence a metallic SWNT (either as an individual tube or within bundle) quenches 
the electronic excitation from adjacent semiconducting SWNTs, significantly reducing 
photoluminescence [166, 171].  
 A limitation of PL lies in the ability of aggregates of the SWNT in solution to quench the 
PL. Ultracentrifugation of the dispersed SWNT solution has been reported to increase the PL 
yield [171]. Therefore PL may provide a unique quantitative method for the evaluation of the 
dispersion efficiency of SWNT in the selected pharmaceutical excipients. 
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1.2.6  Research issues 
 The effective application of CNTs as pharmaceutical and biomedical functional materials 
hinges on the effective control of the purity and aggregate (particle size) control. The efficacy 
and toxicity profile of a pharmaceutical excipient is largely controlled by the purity of the 
materials, particularly for nanoparticles.  Two major research questions will be addressed in this 
work; purity of SWNTs, and dispersion in pharmaceutical agents. 
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2.0 HYPOTHESIS AND OBJECTIVES 
2.1   Aims and hypothesis 
 The use of CNTs as excipients in pharmaceutical delivery will require the development 
of a set of quality control criteria including purity analysis and dispersibility in aqueous 
solutions. The difficulty of the solubilization of pristine CNTs in aqueous solvents is a potential 
obstacle to realizing their application as excipients, due to the rather hydrophobic character of 
the graphene sidewalls, coupled with the strong π-π interactions between the individual tubes, 
causing CNTs to aggregate as bundles. It is particularly necessary to understand the properties of 
CNTs in aqueous media in the presence of pharmaceutical dispersing agents that may be used to 
prepare exfoliated monodispersed SWNTs.  The aim of the project is two-fold; to characterize 
the purity of selected commercially available CNT (“as produced” materials) and, to characterize 
the dispersibility of selected SWNTs prepared using pharmaceutically relevant surfactants and 
solvents. These objectives will rely on the suitability of Raman and UV spectroscopy, dynamic 
light scattering and zeta potential as quantitative analytical methods to describe the dispersions 
and characterization of CNTs. 
 It is hypothesized that selected pharmaceutical surfactants and solvents will be suitable to 
produce dispersed SWNTs in aqueous media by sonication.  However, dispersibility could be 
dependent on the original purity of the starting CNT raw material.  
 
2.2  Specific Objectives  
 The specific objectives of the research will include 
 
 
 
 52
2.2.1   Purity evaluation of commercial SWNT and selection of SWNT for further studies 
i.  Comparative purity analysis of six SWNT samples by Raman spectroscopy. A 
comparison of the RBM peaks will be used to evaluate the diameter distribution of 
SWNT samples, while the ratio of the G/D peak intensities, will be used to determine 
the purity (i.e. SWNT content) of SWNTs. 
ii. Evaluation of the dispersion efficiency of selected pharmaceutical solvents and 
surfactants for a chosen SWNT sample. 
iii. Determine the relation between purity and dispersion efficiency of commercial 
SWNT samples for a selected dispersion medium. 
 
2.2.2  Physicochemical characterization of SWNT dispersions  
 The physicochemical characterization of SWNT dispersion will entail the 
development and optimization of a dispersion method and a quantitative analytical method; 
First, a method will be developed for the dispersion of one SWNT in a surfactant solution 
previously described in the literature (1% w/v SDS) by optimizing the conditions of 
sonication, centrifugation and surfactant concentration. Specifically, 
i. Determine the length of sonication required for maximum dispersion (no further change 
in UV absorbance) of a selected SWNT sample 
ii. Determine the optimum centrifugal force and centrifugation time required to separate 
impurities and aggregated nanotubes from dispersed nanotubes 
iii. Select pharmaceutical surfactants and solvents that have potential as dispersing agents 
based on their biocompatibility, ionization state, HLB and polarity of the solvents (see 
Table 3.1). 
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Table 2.1 Panel of potential pharmaceutically relevant solvents and surfactants for initial 
screening.  
Physicochemical properties Solvent / Surfactant 
MW (gmol-1) *1 HLB*2 CMC (mM) 
Solvents 
Ethanol (100%) 46.07 ▓ ▓ 
Propylene glycol 76.09 ▓ ▓ 
Dimethylsulfoxide 78.13 ▓ ▓ 
PEG 300 190 - 210 ▓ ▓ 
Glycerol 92.0 ▓ ▓ 
Anionic surfactants:    
SDS 288.4 40 8.1 
Monocationic surfactants    
Benzalkonium Chloride 424.2 ▓ 5.0  
Bis-cationic surfactants    
12-2-12 gemini surfactant 614.7 ▓ 0.89 ± 0.04 [172] 
12-3-12 gemini surfactant 628.7 ▓ 0.98 ± 0.04 [172] 
12-7-12 gemini surfactant 684.8 ▓ 0.85 ± 0.07 [173] 
12-16-12 gemini surfactant 754.9 ▓ 0.12 ± 0.01 [172] 
16-3-16 gemini surfactant 740.8 ▓ 0.026 ± 0.001 [174] 
18-3-18 gemini surfactant 797.0 ▓ 0.013 ± 0.001 [173] 
Neutral surfactants    
Poloxamer 188 8,400 >20 8.33 
Poloxamer 338  14,600 >20 ▓ 
Poloxamer 407  12,600 >20 0.079 
Tween 20 1227.5 16.7 0.050 
Tween 60 1311.7 14.9 0.021 
Tween 80 1310 15.0 0.010 
Span 20 346.5 8.6 0.025 
Span 40 402.6 6.7 0.010 
Span 60 430.6 4.7 0.009 
Triton X-100 625 13.5 0.241 
Myrj 52 2043 16.9 N/A 
 
▓     - No data available 
NOTE: HLB values are only relevant for non-ionic surfactants, whiles CMC values are relevant for ionic 
surfactants only. 
* MW – Molecular weight of  solvent molecules and surfactants were take from Ref [175] 
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3.0   MATERIAL AND METHODS 
3.1   Evaluation of CNT samples for magnetic susceptibility 
 Both SWNTs (AP-SWNT, P3-SWNT, CT1-SWNT) and MWNTs (MWNT-15, MWNT-
40 and MWNT-50) were evaluated for their magnetic susceptibility. Subsequently, only the 
responsive CNT sample was used for magnetophoresis, using a magnetic field created by an 
electromagnet.  
 
3.1.1  Materials and Methods I – Magnetic susceptibility 
 Six samples of CNTs were evaluated in the first batch of experiments; three being SWNT 
and three being multi-walled carbon nanotubes (MWNT). For the single-walled carbon 
nanotubes, AP-SWNT (Batch # 155) and P3-SWNT were purchased from Carbon Solutions Inc, 
whiles CT1-SWNT from CheapTubes Inc. P3-SWNT is described as carboxylated SWNTs, and 
hence soluble in deionized water. The MWNT samples of MWNT15 (external diameter <15 nm) 
MWNT40 (external diameter <40 nm) and MWNT50 (external diameter >50 nm) were all 
purchased from CheapTubes Inc (See Appendix A for quality details). 
  To evaluate the magnetic susceptibility of the CNT samples, a 0.1 mg/mL dispersion of 
the CNT was dispersed in deionized water (without sonication). The samples were then placed 
on a magnetic stirrer (Auto Mixer, Fisher Scientific), and allowed to settle prior to turning on the 
magnetic stirrer. When the magnetic stirrer was turned on, a rotating magnetic field was 
generated. The rotating magnetic field caused the responsive CNT samples to be agitated/moved, 
while no movement was observed for non-responsive CNT samples. Using this technique, AP-
SWNT was the only sample observed to be responsive. This was subsequently used to evaluate 
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the efficiency of the spearing of intact SC by these CNTs, under the influence of a magnetic 
force.  
 
3.1.2  Materials and Methods II – SWNT magnetophoresis of stratum corneum 
 Stratum corneum (SC) was harvested from excised human skin using the method 
described in Appendix C. SC was then sandwiched between two layers of parafilm, with a 
window cut into one side of the parafilm, exposing the SC (the exposed outer layer of the SC, 
usually exposed to the elements is oriented to be exposed in the window). A model non-porous 
lipophilic synthetic material, Silastic membrane (SM) was also used. 
 The sandwiched SC-parafilm is then fastened onto the top of a 20 mL glass vial 
(Kimble®), containing 0.1 mg/mL dispersion of SWNT in deionized water. With the SC securely 
held in place, the container is then introduced into the cavity between the two poles of an 
Electron Spin Resonance (ESR) Spectrometer (Bruker EMX EPR Spectrometer, equipped with 
Win-EPR software) for 5 minutes (Fig. 3.1). The effect of the generated magnetic field strengths 
on the efficiency of magnetophoresis was evaluated by exposing the membranes to two different 
magnetic field strengths ; 5000 and 9800 G, each with a sweep width of 100 G. After exposure to 
the magnetic field, the vial was removed, and the membranes (SC and parafilm) carefully 
removed and dried in a desiccator for SEM analysis. To better observe the nanosized channels 
created under the influence of the magnetic field, the above set-up was repeated using parafilm 
as the membrane, rather than SC.  
 The surface of the CNT treated SC and parafilm were examined for pores and location of 
CNT bundles by scanning electron microscopy (SEM) using a Leo FE-SEM at the WatLabs 
(University of Waterloo). 
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Figure 3.1 Schematic representation of magnetically responsive CNTs driven into 
stratum corneum (sandwiched between two layers of parafilm) under the 
influence of a varying magnetic field strength using the magnetic field 
generated between the poles of an Electron Spin Resonance Spectrometer 
(Bruker EMX EPR Spectrometer) 
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3.2  Materials and methods- Evaluation of SWNTs quality 
 Five of highest quality (as described by the suppliers) SWNT were purchased from 
commercial source, and analyzed by Raman and electron dispersive x-ray spectroscopy (EDS). 
These SWNT samples are; AP-SWNT and P2-SWNT, from Carbon Solutions Inc, HMS-SWNT 
from Helix Materials, and NA-SWNT from Nanostructured and Amorphous Materials Inc. (See 
Table 5.1 for purity details). 
 
3.2.1   Raman spectroscopy –Purity of SWNT  
 The purity of as-received SWNTs samples were determined on a Renishaw system 2000 
equipped with a 784 nm laser. A 10-40 mg portion of each SWNT sample was transferred into a 
clean aluminum sample pans (Perkin Elmer). Generally, the laser beam was focused on the 
sample with a 5 X objective of the Raman microscope. To obtain relatively high signal to noise 
ratio (S/N), 10 scan accumulations, with each scan collected for 10 seconds. The Raman spectral 
peaks were calibrated using a silicon peak position of 520 cm-1. 
 
3.2.2    Qualitative EDX Analysis of SWNT Samples 
 About 5mg of each SWNT sample was surface mounted to glass thin-section slides using 
conductive double sided carbon tape, followed by the application of carbon emulsion paint 
between the glass slide and sample holder to maintain electrical contact.  
 Analysis of the mounted samples were conducted on a JEOL 8600 Superprobe electron 
microprobe analyzer (EMPA) operating at an accelerator voltage of 15 kV and a focused beam at 
a current of 10 nanoamps. By scanning over the surface of the samples, impurities are identified 
in backscattered electron imaging configuration at a raster area of  ~ 0.4 mm. This method of 
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imaging causes particles composed of elements heavier than carbon to appear brighter than the 
CNT on the monitor. Once identified, these particles were analyzed qualitatively using energy 
dispersive spectrometry (EDS) to determine their chemical composition.  
 
3.3    Dispersion in selected pharmaceutical solvents - Materials and methods 
 P2-SWNT was used for the initial evaluation of dispersion of selected pharmaceutical 
solvents. All the surfactants were NF quality (See Table 5.5), purchased from Spectrum except 
for gemini surfactants which were synthesized in our research group [172, 173] . AP-SWNT was 
used without further purification.  
 P2-SWNT dispersion were prepared by adding a 0.10 % w/v of ionic and non-ionic 
surfactants in de-ionized water (nominal resistivity greater than 18.0 MΩ cm) and in various 
pharmaceutically relevant solvents to the appropriate amount of P2-SWNT to obtain a SWNT 
concentration of 0.1 mg/mL. The dispersions were sonicated at low power (50 kHz) for 24 hours 
on a Branson 5210 waterbath sonicator (Branson Ultrasonics) at 25 oC. For the optimization of 
the excipient concentration for dispersing 0.1 mg/mL of SWNT, several concentrations of the 
excipient (the gemini surfactant 12-3-12) was used in the method development. After sonication, 
the dispersions were centrifuged on an Allegra™ 25R centrifuge (Beckman Coulter).  
 SWNT stability of the SWNT dispersions was evaluated by UV spectroscopy. Zeta (ζ) 
potential measurements, dynamic light scattering (DLS), Raman spectroscopy, optical 
microscopy, and scanning electron microscopy (SEM).  
 The extent of exfoliation into individual/smaller bundled tubes, and stability of the 
SWNT dispersions were monitored by UV spectroscopy, optical microscopy, and scanning 
electron microscopy (SEM), and Raman spectroscopy.  
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 For dispersion in ionic surfactants, the stability (i.e. ability of SWNT to remain in 
dispersing medium without phase separating) of the dispersion was monitored by zeta (ζ) 
potential measurements, while the particle size distribution of all dispersions was obtained by 
dynamic light scattering (DLS). Raman spectroscopy, was again used to ascertain the exfoliation 
if dispersed samples. 
 
 
3.3.1    Microscopy  
 Optical Microscopy - For optical imaging, 50 µL of the dispersion was carefully drawn 
using and dipped on a glass slide to settle. Images were taken at a 40X magnification on a 
Reichert (Microstar IV) microscope, fitted with an Olympus (Q Color 5 RTV) camera and 
software.  
 Scanning Electron Microscopy (SEM) micrographs were taken using a using a LEO 1530 
FE-SEM (Zeiss). SEM samples were prepared by transferring 5 µL of dispersed SWNTs onto 
pre-heated (~150°C) silicon substrates. 
 
3.3.2    Particle size and zeta potential 
 Carbon nanotube dispersion size and zeta potential measurements were carried out on a 
Malvern NanoZS instrument (Malvern Instruments, Worcestershire, UK) equipped with a 633 
nm He-Ne laser. The system was calibrated for size measurements using NanosphereTM (Duke 
Scientific Corporation) standards of mean diameter of 60 nm ± 2.5 nm, whiles ζ-potential 
transfer standard (Malvern, DTS1050); -50 ± 5 mV was used for used for ζ-potential 
calibrations.  
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 Size and ζ-potential measurements were performed by transferring ~800 μL of dispersion 
into a clear disposable folded capillary cell (Malvern, DTS 1060) at 25 °C and at the natural pH 
of the dispersing medium. The zeta potential was obtained using by laser Doppler 
microelectrophoresis at a frequency of 1000 Hz, while particle size (electrophoretic diameter) 
was obtained using the Non-Negative Least Squares (NNLS) algorithm to distinguish between 
particle size populations.  Zeta potential data was fitted using Smoluchowski approximation and 
reported as intensity distribution. Each data point was automatically repeated in quadruplets, 
with the average reported. 
 
3.3.3    Raman spectroscopy – Evaluation of dispersion 
 The dispersion characterization by Raman spectroscopy was carried out on a Renishaw 
system 2000 equipped with a 784 nm laser. The dispersed sample (200 µL) was transferred into a 
clean aluminum sample pans (Perkin Elmer). All measurements were taken at room temperature, 
and for each sample the Raman data were collected at different light spots on the sample surface. 
Generally, the laser beam was focused on the sample with a 40 X objective of the Raman 
microscope. To obtain relatively high signal to noise ratio (S/N), 20 scan accumulations, with 
each scan collected for 10 seconds. The Raman spectral peaks were calibrated using a silicon 
peak position of 520 cm-1. 
 
3.3.4   Ultraviolet (UV) spectroscopy 
 UV absorption measurements were taken using an Agilent 8453 UV-VIS 
spectrophotometer at λ=500 nm. The UV absorbance spectrum at 500 nm is relatively unaffected 
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by CNTs conditions (such as charge transfer between CNTs and dispersing agents) and has been 
used to estimate NTs dissolved in solutions [109, 128, 176, 177] .  
 The wavelength was selected as dispersed CNT absorbance values followed the Beer-
Lambert law, and more significantly, the absorbance values are unaffected by ambient conditions 
[109, 176-179]. One (1.0) mL of the SWNT dispersions was transferred into a quartz cuvette, 
with a path length of 1 cm. A blank sample of the dispersing agent (surfactant or solvent) was 
used as a reference for background correction.  
 To monitor the exfoliation of CNTs in various dispersion solutions, 1.0 mL of the 
dispersion was withdrawn at set time intervals and the UV absorbance measured as above. 
Similarly, to evaluate the process of centrifugation, 1 mL aliquots of the supernatant (after 
centrifugation) were measured similarly. 
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4.0       RESULTS AND DISCUSSION  
4.1 Magnetic Carbon nanotubes in Stratum Corneum  
 An initial research objective was based on the immobilization of magnetically driven 
SWNT, as drug delivery nanoparticles, into stratum corneum (SC). Our preliminary investigation 
showed that the CNT aggregated as non-dispersed clusters on the surface of the SC, with no 
observable damage to the SC. Hence to achieve our initially set goal, it is paramount that CNTs 
are dispersed in an appropriate medium prior to magnetophoresis.  
 
4.1.1 Results and discussion – Magnetic susceptibility and magnetophoresis of SWNT on 
Stratum Corneum 
 The initial experimental design was to use the magnetic field generated by an 
electromagnetic (EPR machine) to drive CNTs into SC. By modulating the magnetic field, 
aggregates of the magnetically responsive SWNTs were observed to migrate in a set direction, 
with the target membrane (SC and parafilm) immobilized perpendicularly against the direction of 
CNT magnetophoretic movement.   
 AP-SWNT, P2-SWNT and P3-SWNT were magnetically susceptible owing to their 
observed movement when their dispersions were exposed to a magnetic field. The source of such 
magnetism susceptibility can be attributed to one of two sources. The first and most often cited 
source is from remnants of catalytic superparamagnetic particles often used in the synthesis of 
SWNTs [180-185]. These nested (at the tip of SWNTs) paramagnetic nanoparticles have in 
inherent magnetic susceptibility, resulting in a response to magnetophoretic force [180, 184, 186-
189], dragging the SWNTs with them . The second source of magnetic susceptibility is suspected 
to arise from structural defects in carbon based nanoparticles in general [190], and the inherent 
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paramagnetism of carbon nanotubes [191, 192]. Exposing these paramagnetic materials to a 
strong magnetic field, such as that generated in the EPR magnet, can result in observed magnetic 
susceptibity. Following the treatment of SC and parafilm by magnetophoresis, the now “treated” 
SC pieces were retrieved and surface examined by SEM for the presence of SWNT aggregates, 
and any resulting nanochannels/pores that would have been created by magnetophoresis. 
 In the experimental design, two magnetic field strengths were selected (5000 G and 9,800 
G), and the magnetophoretic migration of AP-SWNT and P3-SWNT (dispersed in deionized 
water) towards immobilized SC and parafilm. The maximum field strength generated by the EPR 
machine was 10,000 G. By modulating the field strength at either setting by 200 G, the magnetic 
field created generates a magnetophoretic force, resulting in the movement of aggregated/clusters 
of SWNT. In the aggregated CNT dispersion (i.e. CNT in deionized water), magnetophoresis 
[193, 194] was inferred from the movement of the aggregates in a set direction, stopped only by 
the membrane cap. These visible aggregates were observed to completely migrate onto the 
surface of the membranes in less than 5 minutes. Hence, the time of exposure to the magnetic 
field was set at 5 minutes. 
 The SEM micrographs performed with AP-SWNT dispersed in deionized water are 
shown in Figure 4.1. SEM images of the control SC (no SWNT treatment) treated SC, and 
treated silastic membrane. As expected, the control SC sample shows no visible pores (Fig. 4.1 
A), confirming an intact piece of SC. An examination of the AP-SWNT (Figure 4.1 B) and P3-
SWNT (Figure 4.1 C and D) treated SC samples showed no visible pores on the surface of the 
SC. However, as the SWNT were dispersed in deionized water, these persisted in the dispersions 
as aggregates, which aggregates were observed as clusters on the surface of the SC. 
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 In portions of the P3-SWNT treated SC, smaller clusters of SWNT were observed on the 
SC (Figure 4.1 D), however, the non-rigid nature of SWNTs imply that these clusters tend to coil 
upon contact with the SC, rather than penetrate the membrane. A similar trend is observed when 
a silastic membrane (Figure 4.1 E and F) is used instead of SC. However, dark spots appear on 
the membrane which were absent from the control sample.  
 The investigation into the use CNT created nano-channels on SC, under the influence of a 
magnetic force under the current experimental set-up did not appear feasible for the following 
reasons. Firstly, to successfully create individual nano-channels on the stratum corneum via 
spearing of the individual CNTs, it is imperative to obtain a nano-dispersion (CNTs as individual 
strands, or smaller bundle sizes). Secondly, this could be due to one of several reasons; the 
magnetic properties of the CNT are too weak to be driven by a magnetic force of the order of 1 
tesla (10,000 G), and/or the magnetic field strength of 1 tesla is too weak to cause any observable 
damage to the stratum corneum. 
 To address the issue of aggregated SWNT observed on the SC, it is necessary to disperse 
SWNT in an appropriate media prior to magnetophoresis across the SC. The successful and 
reproducible dispersion of SWNT in selected pharmaceutical solvents will address issues such as 
SWNT purity, an optimized SWNT and surfactant concentration, optimized dispersion 
conditions, and a characterization of the dispersion (stability and size distribution). To this end, 
the specific objectives of the research were subsequently modified to reflect this.  
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Figure 4.1 Magnetically susceptible AP-SWNT treatment of intact human stratum corneum 
and parafilm membranes, using the magnetic field created between the poles of a 
Bruker EMX Electron Spin Resonance Spectrometer; A-Control stratum corneum 
(SC) shows no visible signs of damage. Inserts B, C and D have been exposed to 
0.1 mg/mL dispersions of SWNT magnetically driven AP-SWNT 9,800 G into 
SC shows no visible damage to the SC whiles aggregates of AP-SWNT are 
observed on the surface of the SC; C-No damage is observed in the magnetically 
susceptible acid purified P3-SWNT in SC; D-In places where P3-SWNT appear 
more exfoliated, P3-SWNT lies flat on the SC surface rather than penetrate the SC 
surface; E-On the hydrophobic silastic membrane, P3-SWNT appear to cause 
dark coloration at the surface of the membrane at 9,800 G; F- At a higher 
magnification, the dark spots appear to be indents on the parafilm.  
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4.1.2  Conclusion from SWNT-magnetophoretic study 
 Preliminary investigation into this resulted in two major observations: spearing of SC did 
not appear to be possible at magnetic field strengths of up to 1 tesla, and SWNTs appear as 
bundled aggregates, preventing/obscuring the spearing of stratum corneum by individual CNTs. 
 To overcome these challenges, it was necessary to identify the nature of metals present in 
the SWNT samples, as these could impart magnetic susceptibility to the bulk material. To 
generate the desired nanochannels, using magnetophoresis, it is necessary to disperse/exfoliate 
the SWNT bundles into individual strands prior to magnetophoresis. These findings have thus 
dictated the redefinition of the research objectives. 
 
4.2  Evaluation of SWNTs and the establishment of minimum quality requirements 
 A major bottleneck in the utilization of carbon nanotubes in medicine is the lack of a 
standardized quality analysis [69]. For medical and pharmaceutical purposes, it is imperative that 
the quality of CNT (purity, impurity content and identity, diameter, length, and functionalization 
state) materials be well defined, with little ambiguity. However, a survey of CNT from various 
suppliers at best include a few of these descriptors (see table 4.1 below).The disparity between 
reported purity of CNT materials and those obtained from independent analysis [69, 70] are 
largely due to the heterogeneous nature of the CNT. Typically, CNT from commercial sources 
are accompanied by what is described as product information sheets, purported to contain the 
quality analysis of the accompanying material. Table 4.1 is a collation of the information 
accompanying CNTs. These list the synthetic method, size (diameter and length), purity, 
amorphous carbon content, metallic content, ash, specific surface area, density, melting point and 
aqueous solubility. The details of the accompanying product quality sheets are in Appendix A.  
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The reported purity values have different descriptors; carbonaceous purity (cp) is used for AP-
SWNT, P2-SWNT and P3-SWNT), while weight percentage (wt %) is reported for Cheap Tubes 
Inc (CT-SWNT), no specific units listed for HMS-SWNT, while for NA-SWNT, percentage 
SWNT is used. There are no specified units used for the products of Helix Material Solutions 
and Nanostructured & Amorphous materials Inc. 
 By definition, carbonaceous purity will refer to all carbon allotropes within the sample, 
and hence gives little information on the CNT purity of the sample. It is particularly known that 
MWNT are by-products of SWNT synthesis using EAD. Similarly, the use of ambiguous 
terminology such percentage (or percentage SWNT) has several interpretations, e.g. percentage 
volume or weight. The most appropriate descriptor of purity will therefore be by weight. 
Carbon nanotube samples contain two categories of impurities; metallic catalytic impurities used 
for in the synthesis of CNTs, and carbonaceous impurities. These typically consist of a Raman 
spectrum and an electron micrograph (either by SEM/TEM) with the accompanying elemental 
analysis. It is now common practice to advertise CNT as >95% purity when indeed the sample 
contains >95% carbonaceous content and not nanotube content.  
 Solutions Inc. The internal diameters reported are either as an average as in AP-SWNT, 
P2-SWNT, P3-SWNT, HMS-SWNT and NA-SWNT, or a range as in CT1-SWNT and CT2-
SWNT, suggesting a degree of heterogeneity of the particle size. 
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Table 4.1  Summary of synthetic methods, properties, and purity of carbon nanotubes  
 
Description and Code Synthetic 
Method 
Internal/External 
Diameter (nm) Purity* 
Ash 
Content 
Amorphous 
carbon Length (μm) SSA (m2/g) 
AP-SWNT EAD  1.4 #1 40-60 cp ▓ ▓ 1-5 ▓ 
P2-SWNT EAD  1.4 #1 70-90 cp ▓ ▓ 0.5-1.5 ▓ 
P3-SWNT EAD  1.4 #1 80-90 cp ▓ ▓ 0.5-1.5 ▓ 
CT-SWNT CCVD 0.8-1.6/1-2 >90 wt % <1.5 wt % <3 wt % 5-30 407 
HMS-SWNT/HP-SWNT CVD ~1.3 #2 >90 % <2 % < 5 % 0.5-40 300-600 
NA-SWNT/N&A-SWNT CVD NA/1.1 >90 % SWNT ▓ ▓ 5-30 400 
 
#1     – The diameter of all SWNT samples from Carbon Solutions Inc is reported to have an average of 1.4 nm.  
#2     – The diameter of all HMS-SWNT samples from Helix Material Solutions Inc. per the certificate of analysis is reported to have an average of 
~1.3 nm.  
*     – The reported purity values have different descriptors: Carbonaceous purity (cp) is used for products from Carbon Solutions Inc., while weight 
percentage (wt %) is reported for Cheap Tubes Inc. samples. There are no specified units used for the products of Helix Material Solutions 
and Nanostructured & Amorphous materials Inc. 
N/A – Information not available from the MSDS and certificate of analysis. 
▓     - No data available 
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 It is imperative that CNT purity for pharmaceutical applications have comparatively low 
carbonaceous impurities, and a more homogenous size and length distribution. The ash content 
refers to the nonvolatile inorganic matter of CNT which remains after subjecting it to a high 
decomposition temperature. This contains oxidized metallic impurities. The amorphous carbon 
content identifies the amount of non-CNT carbonaceous impurity (e.g. graphite, fullerenes) 
content of each sample.  This information is not available for samples purchased from Carbon 
 Since it is well accepted that neither Raman spectroscopy, electron microscopy, nor 
elemental analysis can, by themselves be used to establish the purity of the CNT materials, 
fundamental questions regarding the purity values often reported (often times listing only one of 
the aforementioned method) arise. How are the stated purity values obtained; are the quoted 
purity levels reproducible; what do the various terminologies of percentage CNT, percentage 
carbon, weight purity, volume purity, carbon content etc often used by vendors mean?  
 For pharmaceutical applications, the development of a set of parameters reflecting on the 
purity, physical (diameter, length, chirality) and chemical (surface defects, functional groups) 
properties and dispersion state of CNTs is necessary. It is imperative that CNT purity for 
pharmaceutical applications have comparatively low carbonaceous impurities, and a more 
homogenous size and length distribution. Several commercially available CNT samples were 
purchased for purity evaluation. Using the technique of Raman spectroscopy, a comparative 
purity evaluation is used to rank the SWNT samples.  
 
4.2.1   Results and Discussion –SWNT Quality by Raman spectroscopy 
 A typical Raman spectrum of CNT has three intense bands; the radial breathing mode 
(“RBM” band), the D-band, and the G-band. The RBM mode arises from a low-energy vibration 
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(100 – 400 cm-1) of CNT due to the movement of the carbon atoms radially, causing the 
nanotube diameter to expand and contract (radial movement) [138, 195] and partly from the 
tube–tube interactions [196] (Figure 4.2A).  
 The D band appears around 1350 cm-1 and is due to defects in the hexagonal C-C 
network in the nanotubes, and characteristic of all graphitic material. The G-band (1500-1600 
cm-1) is a tangential vibrational mode, arising from the motion of carbon atoms tangential to the 
surface of the nanotube. Two peaks, arising from the vibrations parallel to and perpendicular to 
the axis of the SWNT, are often observed in the tangential mode.  
 The intensity of the D-band, relative to the G-band, is therefore an indication of the 
amount of graphitic impurities in the sample, and often used as an accepted index for the 
estimation of CNT purity [197-199]. By using the ratios of the intensities (G to D bands), the 
issues of fluctuations in the Raman beam and counts are eliminated, as each sample acts as an 
internal standard to itself.  Table 4.2 contains a summary of the intensity (counts) values of the D 
(ID) and G (IG) bands of SWNT samples analyzed. The purity of these SWNTs as reported by the 
vendors is also listed. These are reported as percentage weight purity values unless otherwise 
stated. Other terminology used to describe SWNT purity include carbonaceous purity (used for 
AP-SWNT), percentage CNT and percentage SWNT. Even though these terminologies might 
accurately describe the quality of the SWNT, their definitions could be arbitrary. Two criteria, 
both based on Raman measurements, will be used to rank the purity of six samples of SWNT 
obtained from various commercial sources. The purity of the materials were evaluated using two 
criteria; the ratio of the IG /ID, and full-width-at-half-maximum (FWHM) 
 The first criterion was a comparison of IG /ID ratios of the various SWNT samples. There 
is a direct correlation between the value of the intensity ratios and the purity of the SWNT 
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samples; the higher the ratio, the higher the CNT content/quality [200]. The D-band occurs in the 
range 1200-1400 cm-1 is characteristic of any graphitic material. This is a disorder induced band, 
and hence its intensity mimics the amount of graphitic impurities (non CNT material), as well as 
the defects in the sidewall i.e. defective sites on the continuous hexagonal carbon network, 
introduce some disorder-induced features into the spectra [195].  
 
Table 4.2   Purity evaluation of SWNT by Raman spectroscopy 
    
  Purity*   IG  ID  IG/ID  FWHMD 
P2 70-90 % cp  1419820 82209  17.27  41.25 
AP  40-60 % cm  994864 150182 6.62  52.25 
CT  90 % wt  490789 84339  5.82  55.04 
NA  95 % CNT, 90 % swnt 152449 193469 0.78  57.41 
HMS  >90 % p  561926 110286 0.592  44* 
              
* reported purity of SWNT from commercial source 
cp carbonaceous purity. CT1*- SWNT sample purchased from CheapTubes in 2005, while CT2* were purchased 
(also from CheapTubes) in 2007. 
NA describes the purity of the SWNT in terms of carbon nanotube content (CNT) and single walled carbon nanotube 
content (swnt). 
FWHMD represents the full width at half maximum for the D-band 
 
 The G-band appears around 1500-1600 cm-1 and, similarly characteristic of all graphitic 
materials. Its origin is the tangential mode of vibration of carbon atoms relative to the surface of 
the nanotube. Two peaks, arising from the vibrations parallel to and perpendicular to the axis of 
the SWNT, are often observed in the tangential mode. This purity comparison can not be 
compared from the information contained in the accompanying material analysis report due the 
use of varying terminology to describe the purity of these materials (Table 5.2).  
 73
The Raman spectra were fitted using the Laurentian model of peak fitting. To obtain the various 
intensities of the bands, the area under the fitted curves were used. For the G-band, two 
prominent peaks were routinely fitted; hence the peak with the greater intensity (by area) was 
used in the analysis. Table 4.2 contains the intensity (counts at maximum peak height) of the D 
(ID) and G (IG) bands of six SWNT samples, and the calculated IG/ID ratio. The samples are 
arranged in decreasing order of IG/ID ratio (i.e. P2-SWNT > AP-SWNT > CT-SWNT  > NA -
SWNT > HMS-SWNT).  
 An alternative approach to estimating the purity of CNT samples was suggested by 
Dillon et al.[139]. By measuring the full-width-at-half-maximum (FWHM) of the D and G bands, 
a comparative qualitative estimate of the purity of CNTs is made. The origins of the disorder 
induced D-band and G-bands are a convolution of in-plane vibrations (D-band) of the various 
carbon allotropes (graphite, C60, and other carbonaceous materials), and CNTs. However, the 
FWHM of the D-band of other carbon allotropes are much broader than that of CNT, and a direct 
indicator of the level of carbonaceous impurities.  
 This is measured at the full width of a spectral band at a height equal to half of the height 
at the band maximum. The FWHM is a better descriptor of spectral width when the spectra do 
not have sharp edges. The D-band of CNT, as described earlier, is a convolution of several 
vibrations from CNTs and other carbonaceous material in the sample.  
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Figure 4.2   Stacked Raman spectra of SWNT from various commercial sources showing (A) the  
relative peak intensities of the RBM (100-400 cm-1), D (1100-1400 cm-1) and G 
(1500-1650 cm-1) and (B) the intensity distribution of their relative peaks in the 
RBM region. 
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 Since the RBM is a characteristic feature of only SWNT, the presence of RBM peaks in 
all six samples (Figure 4.2 B) confirms the existence of SWNT in each sample. Even though the 
use of one excitation wavelength (i.e. only specific chiralities are excited) can not be used to 
estimate the diameter distribution of these samples, the spread of the peaks in this region is an 
indicator of the diameter distribution (and hence homogeneity) of the individual SWNT.  
Whereas the two sharp and narrow peaks are observed for P2-SWNT (149, 164 cm-1) and AP-
SWNT (148, 164 cm-1), several peaks are observed for HMS (152, 164, 182, 205, 260 cm-1), NA 
(164, 208, 266, 316 cm-1), and CT (166, 210, 266 and 316 cm-1). This suggests a narrower 
diameter distribution for P2- and AP-SWNTs. However, since the RBM values are inversely 
proportional to the diameter, this narrower diameter distribution will be larger than the smallest 
diameters found in HMS-, CT- and NA-SWNT, since they have RBM active vibrations at > 165 
cm-1).  
 Figure 4.2A shows stacked Raman spectra of the six SWNT samples analyzed. The 
disorder induced D-bands (~1353 cm-1) are indicated by arrows whiles the G-bands (1588 cm-1) 
as shown in Figure 4.2A. The peak positions of both bands in all six samples are relatively fixed.  
The ranking of purity obtained by the FWHM method (i.e. P2-SWNT > AP-SWNT >CT-SWNT 
> NA-SWNT > HMS-SWNT), is significantly different from the intensity ratios.  
 However, this approach appears to be much less sensitive, with the values appearing are 
close in magnitude (47.0-56.6). It is essential to note however, that the purity evaluation as 
defined by Raman spectroscopy takes cognizance of the carbonaceous materials only. Even 
though a sample might have a significant amount of SWNT, the presence of defective sites on 
the tubes will increase the D-band with resulting in a reduced IG/ID ratio.  
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 Using the two criteria (IG/ID, and FWHM) set for purity comparison, Raman spectral 
analyses indicated that P2-SWNT was the best quality of the six samples, while HMS-SWNT 
was the least pure. Based on the purpose of the comparative purity analysis, it has been 
established that P2-SWNT has the best carbonaceous purity, and will subsequently be used for 
dispersion evaluation.  
 O’Connell et al. [166] established that ultracentrifugation can be used to separate CNT 
from metallic impurities, and metallic impurity-CNT composites, by exploiting the differences in 
the density of CNTs and metallic nanoparticles. However, by using gradient centrifugation over 
a 2.5 hour period, Sun et al. [201] demonstrated that similar separation can be achieved by 
gradient centrifugation, with the higher density metallic particles and composites separated by 
controlled sedimentation. It is therefore envisioned that the metallic impurity content of the 
selected SWNT will be further reduced after centrifugation.  
 As mentioned previously, the quality of a pharmaceutical excipient lies partly in 
identifying the impurities present in the sample. To this end, qualitative electron dispersive x-ray 
spectroscopy (EDS/EDX) will be used to identify the metallic impurities in the six SWNT 
samples.  
 
4.3      Qualitative EDX Analysis of SWNT Samples  
4.3.1    Results and Discussion –SWNT Quality by EDX 
 Backscattering electron images confirm the non-homogenous nature of all SWT samples 
analyzed. The backscattering electron images of the EDS analyses show the presence of 
impurities as sharp bright spots, contrasted from the carbon mass (containing CNTs and graphitic 
impurities), allowing for detecting subtle variations in the chemical  composition of the material 
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(material with heavier elements appear brighter).  Table 4.3 contains a summary of the reported 
metallic impurities, and metallic impurities identified in our analysis. EDS backscattering images 
and plots can be found in Appendix A. 
 AP-SWNT samples are shown to contain Ni and Y as particles (0.5-1 μm). The 
accompanying elemental analysis from the supplier indicates the sample contains 40-60 % 
SWNT and 30 % residual catalyst of Ni/Y catalyst. 
 
Table 4.3   EDS backscattering analysis of SWNT  
   
SWNT  Reported Impurities           Impurities by EDX 
AP-SWNT    Ni/Y             Ni/Y 
NA-SWNT   Al, Cl, Co and S.           Si, Cr-Fe-Co Fe-Cr-Mo.                
                                               Trace amounts of Al, Cl, Co, S and Fe, 
HMS-SWNT   None             Fe, Co, S and Si 
CT-SWNT   Al, Cl, Co and S           Fe, Cr, S, Si, Al, Ca, Ti, Cl,  
P2-SWNT  Ni, Cl, S, Si, Y           Ni, Cl, S, Si, Y 
   
CT1*- SWNT sample purchased from CheapTubes in 2005, whiles CT2* were purchased (also from 
CheapTubes) in 2007. 
 
 For N&A-SWNT sample, a piece of Si as individual shard is visible (see accompanying 
SEM spectra), while other particles were identified to contain Al-Si (<1 μm), Cr-Fe-Co (100-500 
nm) and Fe-Cr-Mo (100-200 nm). The carbon mass has trace amounts of Co, Fe, Cl, S, Al. 
The accompanying elemental analysis (in certificate of analysis) indicates the sample consists of 
96.30 % C, 0.08 % Al, 0.41 % Cl, 2.91 % Co and 0.29 % S. For the purity of SWNT samples, a 
quote of the carbon content is of little significance; this includes all other allotropes of carbon. 
The results do show the presence of all the listed elements, and additionally, Fe and Si were 
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found in the sample as well. The presence of Si in the sample is thought to originate from the 
packaging (glass vial) of the material, or the substrate upon which the SWNT were synthesized. 
 HMS-SWNT samples contained significantly large particles of Co (10 μm) and minor 
amounts of Fe. The rest of the carbon mass has trace amounts of Fe, S, and Si. The presence of 
this large micron sized Co may be traced to remnants of metallic catalysts used in the synthetic 
process. 
In the material analysis data sheet accompanying the SWNT, the purity has been quoted as >90 
%, with < 5% amorphous carbon, and < 2 % ash. There is no information as to the possible 
existence of metallic impurities in the sample, contrary to our finding. The presence of metallic 
impurities can be accounted for in the reported chemical vapour deposition (CVD) synthetic 
method used to produce these CNTs. 
 CT-SWNT backscattering images indicated the presence of Fe with minor Cr as particle 
(< 1 μm), as well as Fe-Cr with minor particles of Ca, S, Ti as particle (<1 μm) and particles of 
Si (1-2 μm). The carbon mass contains trace amounts of Fe, Cr, Ca, Cl, S, Si. 
The accompanying elemental analysis (in certificate of analysis) indicates the sample consists of 
96.32 % C, 0.08 % Al, 0.40 % Cl, 2.90 % Co and 0.29 % S. For the purity of SWNT samples, a 
quote of the carbon content is of little significance; this includes all other allotropes of carbon. 
The results do show the presence of all the listed elements, and additionally, Fe and Si were 
found in the sample as well.  
 The EDX analysis of P2-SWNT showed the presence of Ni as particle (100-300 nm). 
Carbon mass contains minor Ni, Cl, S, Si, Y. These are reported by the manufacturers to contain 
70-90 % SWNT and 7-10 % residual catalysts from Ni/Y. The results indicate the presence of 
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additional impurities; Cl, S and Si, which have been listed by the supplier as possible 
contaminants. 
 
4.3.2   Conclusions from SWNT Purity analysis 
 The analyzed samples appear to contain mainly carbonaceous mass, as non-reflective 
background, compared to the reflective metallic particles. However, there are particulates of 
metal catalysts residues in each of the analyzed samples, often containing additional impurities 
not stated in the material analysis data sheet. This could arise from contamination, or the use of a 
less sensitive analytical technique to identify the impurities.  
 The results show that the qualitative impurity identity of the CNT materials is often 
understated. Of the six samples analyzed, only two (AP-SWNT and P2-SWNT) have listed all 
the impurities confirmed by our independent analysis. Interestingly, for HMS-SWNT, no 
mention was made of either the starting metallic catalysts, or the possible impurities. NA-SWNT 
and CT-SWNT and have been demonstrated to contain impurities that were not listed.  
 
4.4 Dispersion of SWNT in selected pharmaceutical solvents  
 From pharmaceutical view point, it is essential that solubility be obtained prior to the use 
of CNT in therapeutic formulations. Despite the abundance of literature regarding CNT 
dispersion, there are no agreed methods of evaluating a dispersion [202].  
 Ultraviolet spectroscopy has been used to evaluate the dispersion efficiency of CNTs and 
the colloidal stability of the resultant dispersion. It has been used to monitor the exfoliation of 
both SWNTs [109, 130, 203-205] and MWNTs [109, 206-208] in surfactant solutions. Jiang et 
al. [209] and Marsh et al.[207] independently evaluated the colloidal stability of CNT 
dispersions by monitoring the sedimentation of dispersed CNT over time by the UV absorbance 
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of the supernatant. Yu et al. [206] monitored the exfoliation of bundles MWNTs in SDS solution 
in a time-dependent study. It was suggested that bundled MWNTs are minimally active in the 
UV region, due to tunnel coupling between metallic and semiconductive SWNTs, allowing for 
the concentration of exfoliated CNTs in solution could be determined. For a given 
MWNT:surfactant ratio, the maximum exfoliation achievable was reported when the UV 
absorbance was a maximum [205].  
 However, even though UV spectroscopy has been used to comparatively evaluate the 
efficiency of exfoliation in individual/smaller bundles of CNTs no publications indicate the use 
of this technique in determining the absolute concentration of individually exfoliated CNTs in 
solution. This is mainly because of the UV activity of smaller sized bundles. For our purpose 
therefore, UV spectroscopy will be used to monitor the exfoliation efficiency.  This has been 
used to monitor the extent of exfoliation of SWNT in gemini surfactant (12-3-12) and SDS. 
 Microscopy techniques such as TEM, SEM and AFM are suited for CNT size and purity 
analysis. However, as these techniques typically measure samples in a dry state, they do not 
adequately represent the suspension state of CNT. The simplest qualitative estimation of CNT 
dispersion is by visual estimation. Several methods have been reported to quantitatively estimate 
dispersion in solution. The most common approaches are UV-Vis absorbance [114, 130, 164, 
210-214], resonant Raman scattering [109, 211, 212, 214-218], small angle scattering [116, 211, 
219-222]. These techniques are best used in combination to confirm dispersion [162]. 
 The concentration estimates of dispersed CNT have been obtained by UV absorbance 
measurements. However, our preliminary investigation indicates that these estimates could be 
misleading, if the amount of non-dispersed material (CNT, carbonaceous impurities, and catalyst 
residue) is not accounted for.  
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4.4.1  Preliminary classification of dispersions based on morphology of dispersions 
 The single most significant contributor to the dispersion efficiency of CNT lies in the 
choice of an appropriate dispersing agent. Besides the dispersing agent, dispersions are often 
accomplished by sonication, and centrifugation to obtain a nano-dispersion (dispersion into 
individual nanotubes or nanosized bundles). These nano-dispersions tend to yield stable 
dispersions, with no visible aggregation over several months.  
 To characterize SWNT dispersions in the selected surfactants, pharmaceutical solvents, 
and biocompatible solvents, the morphology of the resultant dispersions were investigated by 
visual observation, light microscopy, and SEM imaging. It was observed that all nanotube 
dispersions appear homogeneous immediately following sonication. However, a time study of 
the dispersion stability was the criteria used to evaluate the dispersants suitability for nanosized 
CNT dispersions. 
 We have investigated the dispersibility of CNTs in a series of pharmaceutical solvents 
[130], and present visible, microscopic, and SEM images of CNTs in three representative 
solvents using a three-category assessment of dispersibility - aggregated/insoluble, swollen, and 
dispersed based on visual observation. CNTs show no signs of aggregation and phase separation 
resulting in a stable and uniform suspension indicated by a uniform light black/brown colour. 
The dispersed SWNTs show no visible signs of aggregation and phase separation several months 
after sonication. There are currently few techniques that can be used to assess the extent of CNT 
dispersion. A measure of the stability of the dispersion (i.e. formation of visible precipitates over 
time) is typically a good indicator of the dispersion efficiency, however, this approach is 
incapable of distinguishing individual from bundle suspensions of CNT [223].  
   82
 Within an hour of sonication, non-dispersed SWNT aggregate and sediment to the bottom 
of vial, while the swollen and nano-dispersed dispersions have a similar visual appearance within 
24 hours. The nano-dispersed samples are expected to contain both mixture of individual SWNT, 
and small sized bundles as centrifugation at 10,000 g is not expected to completely remove 
smaller sized bundles.  
 Table 4.4 is a collation of the descriptive information of the three categories of 
dispersion, with optical images showing aggregated, swollen and stable dispersions, with their 
corresponding light, and SEM micrographs.  Table 4.4 A depicts the aggregation of AP-SWNT 
in deionized water (representative of aggregated/precipitated state). The SWNT are observed to 
aggregate and sediment to the bottom of the vial in less than 2 hours after sonication. In a light 
microscope, these precipitates are clearly discernible as clusters, under an optical microscope 
(40X) as shown (Table 4.4 A). The corresponding SEM images of these aggregated clusters 
confirm the presence of SWNT, and bundled morphology of the SWNT (Table 4.4 B). 
Similar aggregated samples as in Table 4.4 A and B, were obtained for dispersion in 
benzalkonium chloride, poloxamers 338, 407, and 188, Tween 60 and 20 and Span 40. 
Dispersion of SWNT in 100 % DMSO, propylene glycol and glycerol gave a non-uniform 
quiescent dispersion of the carbonaceous materials (Table 4.4 C and D), which do not aggregate 
into larger clusters, but persists as suspension for several weeks and are described as swollen. 
Images of a swollen dispersion in Table 4.4 C and D were taken of SWNT dispersion in DMSO. 
Light micrographs of the dispersed samples depict the efficient dispersion of carbonaceous 
material. These dispersions are characterized by a uniform distribution of small particles in the 
light microscope (Table 4.4, insert E).  
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Table 4.4   Morphology of CNT dispersion  
Type of Dispersion Optical Micrographs SEM 
Aggregated- Optical microscopy and SEM images of 
SWNT dispersed in deionized water. Aggregation and 
sedimentation sets-in soon after sonication, falling out of 
solution and settling at the bottom of the vial 
  
Swollen - dispersion of SWNT in DMSO. Optical 
micrograph (9 months after sonication) shows both 
aggregates in suspension and at the bottom of the vial. 
SEM images reveal smaller aggregates/bundles of CNT. 
  
A B 
C D
 
8
3
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Dispersed - Optical micrographs of 0.1 %( w/v) 12-3-12 
gemini surfactant show no aggregates, while SEM 
micrographs show exfoliated CNT, resulting in 
individual/nanosized bundles 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
E F 
 
8
4
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 However, due to the presence of other non-CNT carbonaceous impurities in the sample, 
coupled with the limitation of the bath sonication process, some amount of sediment is observed, 
albeit much smaller than the aggregates in non-dispersed micrographs (Table 4.4 inserts A and 
C). The SEM micrographs of the dispersions give more detail as the aggregation states of the 
dispersions are visible. SEM images of non-dispersed SWNT (Table 4.4, insert B) show them as 
a thick and dense aggregate. The presence of SWNT is only discernible at the edges of the 
images as needle-like spikes. For the intermediate dispersion (swollen), SWNTs clusters appear 
to be smaller and more loosely aggregated [224] (Table 4.4, insert D), while for  dispersed 
samples,  shows a relatively less bundled smaller sized aggregates of SWNT. The SEM image of 
CNTs in SDS and 12-3-12 show de-bundled CNTs and very small SWNT bundles [130]. 
 Table 4.5 summarizes the various dispersion states, the chemical structure, mean 
dispersion particle size represented by the hydrodynamic diameter (DH), and the zeta (ζ) potential 
obtained for the selected dispersion agents. The dispersion agents have also been categorized into 
the surfactant types (cationic, anionic and non-ionic). Under this category, non-surfactant based 
dispersions are designated as not applicable (N/A). Dispersions prepared using non-surfactant 
based dispersing agents such as solvents; deionized water (DDH2O), dimethylsulfoxide (DMSO), 
ethanol, propylene glycol, and glycerol, were prepared at 0.1 mg/ml P2-SWNT in 100 % of the 
dispersing agent, whiles all surfactant based dispersions were in 0.1 % ( w/v) of surfactant in 
deionized water.  
 The reported particle size and zeta potential measurements were taken 24 hours after 
sonication (dispersions in DDH2O and ethanol were taken immediately after sonication and again 
after 24 hours). 
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 In ionic surfactant dispersion, colloidal stabilization is explained by the Derjaguin–
Landau–Verwey–Overbeek (DLVO) theory. The ζ-potential of the dispersions is based on the 
Smoluchowski equation (as an approximation to the anisotropic rather than spherical 
morphology of the SWNT). Zeta (ζ) potential measurements of the dispersed SWNT show 
typically have values of magnitude > ±25 mV, while non-dispersed samples have a magnitude 
less than +20 mV. The stability of these colloidal dispersions could be attributed to two factors. 
Models have been proposed [116, 124, 166, 225, 226] for the orientation of the surfactant 
molecules on SWNT. In case of Gemini surfactants, their hydrophobic alkyl groups provide the 
binding with the hydrophobic surface of SWNTs, while the positive charges of gemini head 
groups provide compatibility with the polar solvent aqueous media, thereby preventing 
aggregation due to electrostatic repulsion. 
 Unlike ionic dispersions where the colloidal dispersion is a function of the magnitude of 
the electrostatic repulsion between like charged particles, the major driving force for non-ionic 
stabilized colloidal dispersions is a function of steric stabilization [227]. The three tri-block 
copolymers (Pol. 188, 407 and 338) were chosen with varying molecular weight. Stabilization 
via polymer block copolymers relies on the dual interaction of one block with the solvent while 
the other block interacts with the surface of the particles. However, no difference in dispersing 
capability was observed for the triblock copolymers used in this study.  
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Table 4.5  Structure, classification of excipients and dispersion states  
Name Surfactant 
Type 
Average 
DH (nm) # 
ζ-potential 
(mV) 
Chemical Structure of 
surfactant/excipient 
Dispersion State 
 
DDH2O  
 
N/A 
 
> 6000 
 
- 14.64 ± 5.69 
H
O H
 
Aggregated 
 
DMSO 
 
N/A 
 
*DNSA 
 
*DNSA S
O
 
Swollen 
Isopropyl 
Alcohol 
 
N/A 
-  
 
-10.6 ± 12.3 OH  
 
Aggregated  
Propylene 
Glycol 
 
N/A 
 
*DNSA 
 
*DNSA 
OH
HO  
Swollen 
Glycerol N/A 700 *DNSA 
OH
HO OH
 
Swollen 
TX100 
 
Non-ionic 294  - 9.65 ± 8.25 O O H
n
 
Aggregated 
 
Span 60 
 
 
Non-ionic 
 
94.6 
 
 
- 18.6 ± 10.52 
HO
O
OH
O
O
7
HO  
Dispersed 
 
Span 40 
 
 
Non-ionic 
 
331  
 
 
- 27.6 ± 9.69 
HO
O
OH
O
O
6
HO  
  
Aggregated 
 
8
7
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Pol. 338/ 
Pluronic 
F108 
 
Non-ionic 
 
206  
 
-21.0 ± 6.34 OH O O OHa ab  where a = 141,  b = 44 
 
Dispersed 
 
Pol. 407/ 
Pluronic 
F127 
 
Non-ionic 
 
141 
 
 
-12.9 ± 5.85 
OH O O OH
a ab         where a = 101, b = 56 
 
Dispersed 
 
Pol. 188/ 
Pluronic F68 
 
 
Non-ionic 
 
196 
 
 
-15.0 ± 4.98 
OH O O OH
a ab         where a = 80, b = 27 
 
Dispersed 
 
Tween 80 
 
 
Non-ionic 
 
164  
 
 
- 7.39 ± 6.52 
HO
O
O
O
O OH
O
O
OH
O
O
3 3
a
b
c
d-1   
where a+b+c+d = 20 
 
Dispersed 
 
Tween 60 
 
 
Non-ionic 
 
234  
 
 
-11.25 ± 12.36 
HO
O
O
O
O OH
O
O
OH
O
O
*
a
b
c
d
*
7
 
where a+b+c+d = n 
 
Aggregated 
 
Tween 20 
 
 
Non-ionic 
 
332  
 
 
-3.54 ± 4.68 
HO
O
O
O
O OH
O
O
OH
O
O
*
a
b
c
d
*
4
 
where a+b+c+d = n                                                        
 
Aggregated 
8
8
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SDS 
 
Anionic 
264 
81.4 * 
 
-60.54 
O
4
Na+S
OH
OH
O-
 
 
Dispersed 
 
BAC 
 
Cationic 
 
268  
 
+28.5 ± 9.36 
N R
Cl
 R = C8H17 – C18H37 
 
Aggregated 
 
12-2-12 
 
Cationic 
 
227  
 
+39.7±15.1 
N+
N+
C12H25
Br- Br
-
C12H25
 
 
Dispersed 
 
12-3-12 
 
Cationic 
 
308  
 
+66.0 ± 18.5 C12H25
N+ N+
Br-
C12H25
Br-
 
 
Dispersed 
 
12-7-12 
 
Cationic 
 
232  
 
+62.0±15.3 
N+
C12H25
Br- C12H25N+
2
Br-
 
 
Dispersed 
 
12-16-12 
 
Cationic 
205  +64.9 ±29.5 
C12H25N
+
Br-
N+C12H25
Br-
7  
 
Dispersed 
 
16-3-16 
 
Cationic 
 
357  
 
+48.3.0 ± 15.8 C16H33
N+ N+
Br-
C16H33
Br-
 
 
Dispersed 
#   Reported values are the average hydrodynamic diameter of aggregates 
* DNSA- Data not suitable for nalysis.a 
8
9
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 The higher molecular weight surfactants and polymers increased the dispersion of CNT, 
due to steric stabilization by adsorbed surfactant/polymer onto the walls of the CNT, impeding 
CNT aggregation. This may explain the dispersion trend within the Tween (20, 60 and 80) non-
ionic surfactants with molecular weights (MW) of 1227.54, 1283.65 and 1309.68 g respectively. 
Considering these have the same hydrophilic head-group, the difference in dispersion can also be 
explained by the degree of hydrophobicity of the alkyl tail.  
 Having established the general dispersibility of CNT in selected pharmaceutical 
dispersing agents, the focus of the dispersion was further narrowed down to dispersion in gemini 
surfactants, specifically, the 12-3-12 gemini surfactant. At a surfactant concentration of 0.1 % 
w/v, SWNT was dispersed in all the gemini surfactants investigated. It is suggested that the 
stabilization of SWNT in dispersion results from a perpendicular orientation of surfactant 
molecules to the CNT axis, resulting in a monolayer coating. The hydrophobic tail of the 
surfactants are adsorbed onto the graphitic CNT wall via van der Waals interactions, while the 
hydrophilic head-group of the surfactants are oriented away from the CNT wall, and towards the 
aqueous phase. A dispersion of this monolayer of cylindrical surfactant (ionic) coating on the 
CNT surface will be stabilized by electrostatic repulsion induced by the net charges on the 
surfactant coated CNTs [226, 228, 229].  
 The dispersion of CNTs in pharmaceutical solvents and surfactants is due to the 
adsorption of these dispersion agents onto the surface of the CNTs. For ionic surfactants, the 
stability of the dispersion results from the creation of a distribution of charges (either negative or 
positive), on the surface of the CNTs, preventing the aggregation of the dispersed tubes by 
coulombic repulsion. However, the mechanism of the adsorption onto the surface of CNTs, and 
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the orientation of the adsorbed molecules is not obvious. Several postulates have been put 
forward to explain the binding mechanism, and the structure of the resultant CNT-moiety. 
There has been suggestions however, that a more energetically stable surfactant coating, rather 
than the formation of the cylindrical micelles is possible [228]. In a parallel conformation (i.e. to 
the tube axis), hydrophobic tails can interact with the CNT sidewalls by van der Waal’s forces; 
the magnitude of which will depend on the hydrophobicity of that moiety.  
 Using this model of increased stability via van der Waals interactions, coupled with the 
electrostatic repulsion, dispersion stability will be dependent on the magnitude of the 
hydrophobic surfactant tail-CNT van der Waal’s interaction and the charge and size of the 
hydrophilic head-group of the surfactant [124].Islam et al. [124] speculated that surfactant 
dispersed SWNT stabilization is dependent on the interaction between molecules oriented 
parallel to the tube axis and the hydrophobic CNT surface. The dispersions are improved if the 
hydrophobic chains are aligned parallel to the tube axis, rather than perpendicular. 
 By this mechanism, hemimicelle formation results from micelle collapse near the CNT 
surface, resulting in increased absorption near the CMC of the surfactant [230]. However, 
considering the structural stability of hemimicelles, these are stable upon a flat surface [230, 
231], rather than on high curvature structures such as CNTs [226], thus suggesting that the 
formation of hemimicelles is an unlikely mechanism for stabilizing dispersions. 
 It has been suggested that the absence of any structural information from small-angle 
neutron scattering experiments for the dispersion of SWNT using 0.1-1 mg/mL of SDS for a 
final SWNT concentration of 7-12 mg/mL of SWNT [116], suggests the absence of the models 
proposed. Baskaran et al. [232] suggest a random model, where interactions between the 
surfactant and CNT is of random fashion, with no consistent orientation of either the 
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hydrophobic moieties or the polar head-groups. Due to the extensive π-network due to the 
aromatic rings, CNTs are an electron rich moiety, capable of acting as electron donors in donor-
acceptor complexes. Secondly, due to the extensive aromatic network, they are also capable non-
covalent π- π interactions with electron rich moieties.  
 These proposed mechanisms for the dispersions are based on the model that CNTs do not 
have structural imperfections. However, the presence of structural defects makes such 
predictions even more complicated. It is known that the CNTs are electron-rich molecules and 
any electron-deficient molecules can interact with them and form donor-acceptor complexes, 
much the same way as the electron-rich molecules form π-π complexes. The π-π interactions of 
CNTs with electron-rich molecules have been used for noncovalent functionalization.  
 The polysorbate series of excipients (Tween 20, 60, and 80) were selected due to their 
use as emulsifiers and stabilizers for emulsions and suspensions, while the pluronic (Poloxamer 
118, Poloxamer 338, and Poloxamer 407) surfactants are routinely used in pharmaceutical 
formulations. Both of these classes of compounds are reported to have a relatively low toxicity, 
and nonirritating properties.   
 From the chemical structure of Pluronics, it is postulated that the interaction between the 
hydrophobic polyoxypropylene block to the CNT surface on one hand, and that between the 
hydrophilic polyoxyethylene chain interacts with the aqueous phase, resulting in steric 
stabilization [133]. However, at the concentration of 0.1 % Pluronics, there was no observable 
dispersion of the AP-SWNTs whereas visible dispersion was observed for P2-SWNT. 
Moore et al. [118] reported the dispersion of SWNTs in Pluronics with mass percentage 
conversions up to 9.4 %.  
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4.4.2   Method development-SWNT in gemini surfactants 
 It is essential that SWNT dispersions be well characterized and preparations reproducible. 
This is necessary considering the disparity reported for the maximum dispersion of SWNTs; as 
much as two orders of magnitude [124, 131, 229].  These inconsistencies can be traced to one or 
more of several factors.  The methods are developed in different laboratories using different 
processing conditions and different SWNT samples (from different sources). In our method 
development, we will investigate the effect of SWNT source (from five commercial sources) and 
purity on the dispersion efficiency (UV absorbance), optimize the sonication time required by 
monitoring the UV absorbance of the dispersion with time, establish an optimized centrifugation 
speed that will yield CNT dispersions with hydrodynamic diameters (size) <100 nm using the 
selected gemini surfactant (12-3-12). 
 4.4.2.1   Sonication and evaluation of SWNT Samples 
 Sonication in itself enhances the micro-scale dispersion of nanotubes within the 
dispersing medium [233]. However, the conditions used by various researchers vary 
considerably [117, 132, 234]. Sonication of CNT dispersions is the source of mechanical energy 
required to exfoliate the bundles of CNT into individual robes and smaller sized bundles. The 
simultaneous addition of stabilizers such as surfactants, retains the exfoliated CNTs in a 
dispersed state for periods of time [124, 130, 132, 203]. The mechanical energy from sonication 
is required to overcome the van der Waals interactions in the CNT bundles, resulting in tube 
exfoliation. The efficient dispersion of CNTs depends on an optimized sonication procedure, an 
optimized dispersant concentration and CNT concentration.   
 Initial reports suggested that exfoliation and dispersion efficiency was a function of 
sonication power [203]. However, even with sonication, optimized power is required, beyond 
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which the exfoliation process becomes dynamic; the rate of re-aggregation of the individual 
CNTs, equals the rate of exfoliation [215]. Figure 4.3 shows the exfoliation profile of SWNTs 
from five different commercial sources, monitored by UV spectroscopy. The degree of 
exfoliation was monitored by UV spectroscopy appears to plateau after 10 hours of sonication. 
Even though the exfoliation process might not be complete, the attainment of a plateau after ~10 
hours suggests the exfoliation process attains a dynamic equilibrium. 
 In all five SWNT samples evaluated, a common feature was the attainment of a threshold 
maximum (i.e. UV absorbance plateaus with sonication) [132]. As indicated, the optimized 
exfoliation condition is dependent on both the dispersant and SWNT concentrations and the 
strength of the inter-tube attractive van der Waal’s forces in a given sample. The initial 
evaluation of surfactant to SWNT starting weight ratio of 0.1 mg/mL of SWNT dispersed in 0.1 
% w/v of surfactant was selected on the basis of the reported surfactant aided SWNT dispersion 
ratios  published in the literature [124, 132, 217, 235]. However, it is well established that the 
maximum dispersion of CNT varies with dispersion agent. Hence all SWNT samples were 
evaluated using the same dispersion agent/medium (0.1% (w/v) 12-3-12).  
 To optimize the length of sonication required to obtain the maximum exfoliation, the UV 
absorbance of all SWNT dispersed in the same solvent was monitored over a 24 hr period 
(Figure 4.3). 
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Figure 4.3 UV spectroscopy (λ =500 nm) monitoring of the exfoliation profile of 0.1mg/mL 
sonication aided dispersion of SWNTs from four commercial source (SWNT-AP2 
Batch # 155 and P2-SWNT (70-90 % purity) from Carbon Solutions Inc,  HMS 
from Helix Materials (90 % SWNT purity), and NA from Nanostructured and 
Amorphous Materials Inc (C1284YJ 7440-44-0, 95 % CNT, 90 % SWNT) in 0.1 
% w/v of an aqueous solution of 12-3-12 gemini surfactant) with sonication of 
50/60 kHz over a 24 hr period. The UV absorbance of the dispersion increases 
from 0-12 hrs, stabilizing thereafter (grey area) for all five SWNT sample (n=4)  
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 Sonication is used as a source of the mechanical energy, to overcome the strong inter-
tube attractive van der Waals forces inherent in the bundled/aggregated SWNTs, leading to the 
disentanglement and dispersion of exfoliated SWNTs. The shapes of the dispersion patterns are 
the same for all the SWNT samples investigated (i.e. UV absorbance increases for the first 12 
hrs, and plateauing thereafter). However, P2-SWNT and AP-SWNT have a higher absorbance 
value at the maximum exfoliation. These differences can be attributed to two possible routes; the 
weaker intertube van der Waal’s forces in EAD synthesized SWNT (AP-SWNT and P2-SWNT), 
compared to the CVD synthesized SWNTs (CT-SWNT, NA-SWNT and HMS-SWNT), or the 
lower SWNT content of the CVD synthesized SWNTs. In the former, higher energy input will be 
required to disrupt the intertube forces to obtain comparable (to AP- and P2-SWNT) exfoliation, 
and hence UV absorbance. The latter presupposes that a higher SWNT content of the EAD 
synthesized SWNTs, will yield a higher population of exfoliated SWNTs, resulting in their 
observed higher UV absorbance values. 
 The choice of UV spectroscopy as a quantitative measure of SWNT exfoliation is 
justified by the fact that only exfoliated CNTs are UV active in the wavelength region between 
200 and 1200 nm, whereas the bundled and aggregated CNTs are not active due to tunnel 
coupling between metallic and semiconducting SWNTs [132]. However, since the non-UV 
active bundles/aggregates, significantly contribute to scattering the lower UV region, hence 500 
nm was chosen to monitor the UV absorbance. Similarly, UV measurements were taken without 
centrifugation. 
 Continuous exfoliation from bundled SWNT aggregates, into individual SWNTs is 
observed by a corresponding increase in UV absorbance. It also implies that at the point of 
maximum UV absorbance (i.e. where the UV absorbance plateaus after 12 hours), a dynamic 
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equilibrium of exfoliation and re-aggregation of previously exfoliated SWNTs, is attained. The 
continuous increase in absorbance from 0-12 hr of sonication indicates an increase in exfoliation, 
attaining equilibrium as evidenced at the highest absorbance value, corresponding to the 
maximum exfoliation for each SWNT sample. 
  However, exfoliation does not mean the existence of SWNT as individual entities in 
dispersion. This is because, exfoliated SWNTs could still be very loosely entangled aggregates in 
solution, considering the rather high aspect ratios of these materials. By extrapolation, UV 
method has also been used as an indicator of the measure of colloidal stability of SWNT 
dispersions, by monitoring the UV absorbance over time. Under the experimental conditions, we 
conclude that to obtain the maximum exfoliation, the dispersion should be sonicated for a 
minimum of 12 hours. 
 4.4.2.2    Centrifugation of SWNT dispersion 
 Ultracentrifugation is the most common approach used to remove non-soluble 
carbonaceous impurities, remnant metallic particles, and bundles of CNT above a predefined size 
cut-off [103, 115, 125, 131, 204, 225, 236-240]. The defined size cut-off point is usually set at 
the size of the individual tube diameter [103].  However, this is often achieved with a loss of a 
significant amount of CNTs [103].  
 Rather than using the approach of ultracentrifugation to obtain isolated CNTs/small sized 
bundles, Bergin et al. [104, 106] found that a systematic dilution of sonicated CNTs in an 
appropriate solvent/dispersion medium is a superior technique to obtaining individual/small sized 
bundles of CNT dispersions. A concentration-dependent CNT bundle diameter distribution was 
obtained for CNT concentrations less than 0.05 mg/mL, with a size saturation of 2 nm. These 
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findings suggest that the extreme conditions of ultracentrifugation are not necessarily required to 
obtain exfoliated CNTs. 
Using this approach of dilution instead of ultracentrifugation, Cathcart et al. [103] postulated that 
the increased proportion of individual CNTs via dilution results from the lowered probability of 
single CNTs re-aggregating due to the increased intertube separation upon dilution.   
 Centrifugation has been used in the separation of individually exfoliated SWNTs from 
bundled/aggregated SWNTs, carbonaceous impurities, and residual metallic particles. This has 
been achieved by exploiting the differences in the rate of centrifugal sedimentation of these 
components [241].  Also, considering that only exfoliated SWNTs are UV active, a continuous 
monitoring of the absorbance, with a corresponding increase in centrifugal force, will ascertain 
the optimum force required to separate the aggregated/bundled SWNTs, and the residual 
catalytic materials, from the exfoliated SWNTs. Since the UV absorbance of CNTs is 
proportional to the amount in suspension, monitoring the absorbance with varying centrifugation 
is used to quantitatively establish, the speed at which UV responsive dispersed CNTs begin to be 
removed from solution. To optimize the centrifugation speed (removing non-dispersed 
component), UV absorbance was used to monitor this process as for 0.1 mg/mL P2-SWNT in 0.1 
% [12-3-12] (diluted in 1:20 for UV reading), centrifuged at varying speed/force (g). 
 Figure 4.4 shows the variation of UV absorbance (λ = 500 nm) with varying centrifugal 
force for a dispersion 0.1 mg/mL AP-SWNT in 0.1 % w/v 12-3-12. The UV absorbance of the 
dispersion appears to remain stable at 2.3 from 0-10,000 g. However, there is a continuous 
sedimentation of black precipitates as the centrifugal force increased from 0 to 10,000 g, without 
a change in UV absorbance. It is suspected that these dark precipitates consist of the non-UV 
active aggregated/bundled SWNTs, and remnants of the catalytic starting material. 
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 However, beyond 10,000 g, the UV absorbance value begins to decrease consistently 
from a value of 2.3 at 10,000 g, to 1.6 at 24,000 g.  Going by the premise that only exfoliated 
SWNTs, are UV active, we conclude that 10,000 g, is the optimum force of centrifugation, 
beyond which exfoliated SWNTs are additionally removed from the dispersion. Hence, the 
optimized centrifugation speed was therefore established to be 10,000 g.  
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Figure 4.4 The effect of centrifugation on the UV absorbance of the 0.1 mg/mL AP-SWNT 
dispersed in 0.1 % w/v [12-3-12] aqueous gemini solution. The UV active 
dispersants remain in the dispersion until the threshold value of 10,000 g (arrow). 
Beyond 10,000 g, the heavier aggregates begin to sediment resulting in a lower 
UV absorbance.  
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 To establish the presence of nano-sized dispersion (<100 nm) in solution, we monitored 
the particle size distribution (hydrodynamic diameter, DH), of the dispersions above by dynamic 
light scattering.  Even though SWNT are rod-like in nature, the Stokes-Einstein relationship 
approximation can be used for size analysis. However, since the polydispersity index (pdi) value 
for these dispersions is over the critical value of 0.2, the particle size distribution will be 
considered as polydispersed. This is understandable considering that there is a wide variation in 
AP-SWNT lengths from 1-5 μm (Table 4.1), and an expected variation in tube diameter. The 
polydispersity is therefore expected to arise from the varying sizes of SWNTs-surfactant 
conjugates.  
 
Table 4.6 Particle size distribution of AP-SWNT in 0.1 % (w/v) 12-3-12 gemini 
surfactant after centrifugation 
     
Centrifugal         DH Peak     Intensity 
Forge (g)  Peak 1  Peak 2  Intensity 1  Intensity 2 
24000   91  615.1  12.9   0.4 
20000   91  615.8  11.5   0.3 
16000   91  1990  11.3   0.1   
12000   91  712.4  13.6   0.3   
10000   91  458.7  13.5   0.6   
8000   91  5560  12.2   0.2  
5000   122.4  5560  12.2   0.2   
2000   141.8  5560  11.6   0.2   
1000   190.1  1106  13.3   0.4 
0   295.3  5560  8.2   0.7 
  
 
 The dispersions obtained at all centrifugation speeds yielded a mixture of nano-sized 
particles (<100 nm) and macro-dispersions (from metallic and carbonaceous impurities and non-
exfoliated bundles) resulting in the poly-dispersed sizes shown in Fig. 4.5 (0 centrifugation). The 
size of the particles in the CNT dispersions are difficult to interpret due to the polydispersity 
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imposed by the varying sizes of individual bundles, and aggregates of non-dispersed 
carbonaceous impurities.  
 Hence, an interpretation of the size distribution will focus on minimum DH at the defined 
centrifugal force, and the corresponding intensity at the defined hydrodynamic diameter (Figure 
4.5). Figure 4.5 A shows a plot of the particle size distribution for each sample, while figure 4.5 
B shows in detail, the shift towards smaller diameter (particle size), as the centrifugal force is 
increased.  
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Figure 4.5 The hydrodynamic size (diameter) distribution of 0.1 mg/mL AP-SWNT 
(dispersed in 0.1 w/v 12-3-12 gemini  surfactant) with varying centrifugal 
speed. (A) General  distribution shows a size distribution spanning from 
100 nm to macro sized particles of size > 6000 (B) Increasing the 
centrifugation from 0-10000 g results  in a reduced minimum size value 
<100 nm, and (C) a corresponding absence larger aggregates > 100 nm 
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 A look at the plots for the size distribution using this approach shows the removal 
of larger sized particles (>1 μm). A reduction in the particle size distribution of AP-
SWNT is observed as the centrifugal force is increased from 0 to 8,000 g.  An increase in 
the centrifugal force beyond 8,000 g, does not result in a further reduction DH of  91 nm 
(See Table 4.4), with a relatively stable peak intensity of 11.3 -13.5 %. Similarly, all 
samples centrifuged at > 8000 g (except for 16,000 g) have only one other significant 
peak (i.e. with intensity > 0.1 %) after peak 1, has a size less than 500 nm (0.5 μm). 
However, for centrifugation below 8000 g, peak 1 appears to decrease as the centrifugal 
force is increased from 0 g (i.e 295.3 nm) through 5000 g (122.4), with a significant 
particle population of peak 2 at 5560 nm ( except for 1000 g).  
Based on the size distribution of AP-SWNT and the corresponding UV absorbance 
results, we conclude that the optimized centrifugal force of 10,000 g, removes most of the 
aggregated SWNT bundles/impurities, while yielding an increase in population of 
exfoliated SWNT in 0.1 w/v % 12-3-12. 
 4.4.2.3    Optimizing dispersant concentration for maximum exfoliation 
 For dispersion of SWNTs, it is necessary to identify the minimum amount of 
surfactant that produces a stable dispersion for obvious reasons. To this end, zeta 
potential of the as prepared dispersions, are used as a measure of stability for the 
dispersion. Hence, a consistently increasing zeta potential is an indication of binding of 
surfactant molecules onto the SWNT surface, while a saturation of absorbed surfactant 
molecules onto the SWNT surface is reflected by a stable zeta potential value. Figure 4.6 
shows a zeta titration of 0.1 mg/mL AP-SWNT with 0.1 % w/v 12-3-12 gemini 
surfactant. Similar results have been obtained for P2-SWNT. 
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Figure 4.6   Concentration dependence of the ζ-potential (Zeta) distribution of 12-3-12 in 
0.1mg/mL AP-SWNT. The zeta potential increases from -15 to 40 mV 
with a corresponding increase from 0 to~0.075 mg/mL of gemini 
surfactant. Above a concentration of 0.075 mg/mL, there is little change in 
the zeta potential, suggesting a saturation of binding to SWNT surface. 
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 Dispersion of SWNT by ionic surfactants results from the interactions of the 
hydrophobic tail of the surfactant and the hydrophobic walls of the SWNT on one hand, 
and the polar head group with the polar solvent.  By the Derjaguin, Landau, Verwey and 
Overbeek (DLVO) theory, a stable dispersion is expected for ionic dispersions with a   
-35 mV>ζ>35 mV. Figure 4.6 shows the ζ-potential titration of 12-3-12 in 0.10 mg/mL 
SWNT to determine the minimum amount of surfactant to produce high enough ζ-
potential for a stable dispersion. For the 12-3-12 gemini surfactant, the minimum 
concentration required for dispersion is 0.05 % (dotted red line). The ζ-potential 
increased with increasing concentration over the range of 0 - 0.75 % (w/v), suggesting the 
continuous absorption of the 12-3-12 onto the SWNT. Beyond this range, the ζ-potential 
remains relatively constant indicating a saturation of the amount of gemini adsorbed onto 
the surface. It is observed that below the critical micelle concentration (cmc) of the 12-3-
12 (0.89 mmol L-1 ≡ 0.056 % (w/v)), the ζ-potential is not sufficient to retain SWNT in 
dispersion. Hence for the dispersion by subsequent gemini surfactants, the surfactant 
concentrations were chosen to be above their relative cmc values. 
 The hydrophobic alkyl tails of gemini surfactant provides the binding with the 
hydrophobic surface of SWNTs, while the positive charges of gemini head groups 
provide compatibility with the polar solvent aqueous media, thereby preventing 
aggregation due to electrostatic repulsion.  
 4.4.2.4    Raman Spectroscopy 
 The effectiveness of SWNT dispersion can be monitored by the increase in peak 
intensity of peaks in the RBM mode, and/or a shift in peak in the G-band [215, 242]. The 
interaction between nanotubes and dispersing agent is reflected by a peak shift or a peak 
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width change. The presence of binding to the exterior SWNT walls results in a shift in the 
vibration frequencies of both radial and tangential movement of the carbon atoms, which 
is generally indicative of strong attractive forces between a moiety and the CNT [109, 
243]. Figures 4.7 and 4.8 show the Raman spectra of aqueous dispersions of SWNT in 
gemini surfactants and anionic and non-ionic surfactants respectively.  
 Dispersion of SWNT is accompanied by an observable shift in peak is observed in 
the G-band of the Raman spectrum for the gemini dispersion of SWNT (Figure 4.7). For 
all the gemini surfactants investigated, the G-band of the dispersion showed an upward 
peak shift from 1574.5 cm-1 (using SWNT dispersed in DDH2O as reference-arrowed 
peak) to 1573.2 cm-1. Generally, a shift in peak is indicative of an interactive force 
between the dispersing agent, and the SWNT.  
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Figure 4.7 Raman spectra of aqueous dispersions of SWNT in 0.1 % w/v gemini 
surfactant solutions, showing the G-band peak shift from 1574.5 cm-1 (for 
the reference aggregated/precipitated dispersion in water) to ~1573.2 cm-1 
for the resulting stable dispersions SWNT in water.  
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 Sinani et al. [109] explained the shift in peak as a consequence of the wrapping of 
the surfactant/polymer around the exfoliated SWNT. For the gemini surfactants, we 
postulate that an energetically favorable interaction will consist of a hydrophobic 
interaction between the alkyl tails of the surfactants and graphene walls of the SWNTs on 
one hand, and the interaction of the polar quaternary amine head-group of the gemini’s 
with the solvent. This favourable interaction increases the effective diameter of the 
SWNT, and hence the energy required for vibrations to occur. This is reflected in the 
shift to higher frequency of Raman peaks [109].  
 The initial peak position is assumed to be that obtained for the non-dispersed 
SWNT in DDH2O at 1574.5 cm-1 (Figure 4.8), while the dispersions have a consistent 
downshifted value of 1573.5 cm-1. Irrespective of the mode of interaction, a positive 
interaction will invariably lead to an increase in the harmonic oscillator, and hence a 
shift. 
 Comparing the collated spectra, it is observed that, on successful dispersion of 
SWNTs in surfactants via sonication followed by centrifugation, individual exfoliation of 
SWNTs is achieved. This is revealed by the peak position of the G band peak. 
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Figure 4.8 Raman spectra of the shift in G-band peak for SWNT dispersed in selected 
pharmaceutical excipients, relative to the non-dispersed (Water). The peak 
shift for nanodispersions is indicated by a peak shift, relative to the 
reference dispersion in water 1574.5 cm-1(dotted line). 
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5.0 CONCLUSION AND FUTURE WORK 
 The findings of this research work shows that the long term goal of nanofluidic 
delivery of pharmaceutical agents using SWNTs can be explored after the two major 
issues of purity. The application of SWNTs in biological systems depends on their 
compatibility with hydrophilic environments; therefore, the solubilization of SWNTs in 
pharmaceutical solvents is essential. The dispersion of SWNTs depends on the purity and 
method of dispersion, and the characterization of the dispersion states of SWNTs (i.e. 
ascertaining that exfoliated SWNTs are present), can be achieved via sonication, 
followed by centrifugation.  
 
 
5.1    Purity of SWNTs as potential pharmaceutical excipients  
 For purposes of pharmaceutical and biomedical uses, it is apparent that the quality 
of SWNTs could obviate research findings, mainly due to presence of unlisted impurities. 
This concern has led to formation of a working group by the International Organization 
for  Standardization (ISO- TC229/WG2), mandated to establish and recommend protocols 
and standards for the measurement of CNT purity [244]. The work reported in this thesis, 
of inconsistent terminology used in describing the purity of SWNTs by various SWNT 
commercial sources, and the methods used to establish purity, buttress the need for these 
protocols and standards.  
 Additional to establishing the purity (amount of SWNT by weight), there is a need 
to identify the various impurities/residual catalytic materials present in each batch of 
material. It is therefore necessary that a paradigm of quality control and standards be 
established for these materials.  
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 To this end, a mini-monograph is compiled (Figure 5.1), and serves as a starting 
reference, upon which a more complete monograph on the subject of CNTs as 
pharmaceutical materials can be developed. Issues of SWNT purity have been raised, and 
comparative evaluation methods such as EDX and Raman spectroscopy suggested. 
However, to make these methods stand alone, it is absolutely necessary to have an 
industry standard (reference material). As potential pharmaceutical excipients SWNTs 
are regarded as inert/nonactive components of dosage forms, but they are essential and 
necessary components of pharmaceutical preparations. Below is a summary of a 
collection of data to initiate the description of CNTs in general as pharmaceutical 
excipients (Figure 5.1). 
 A second stage of this discussion will involve the establishment of limits for the 
impurities inherent in the SWNTs (metallic and carbonaceous). However, these values 
can only be set after the toxicity of the impurities have been established and quantitative 
methods establishing the concentration of such impurities in a given sample.   
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* Visible and SEM images of CNTs courtesy of Dr, Jun Chen, Intelligent Polymer Research Institute, Univ. of Wollongong, Australia 
 
Figure 5.1 A collation of the physical properties of CNTs, organoleptic properties, 
and dispersion states in representative pharmaceutical solvents [59, 64].  
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5.2  Dispersion of SWNT  
 The dispersion of SWNT in pharmaceutical excipients is the first step towards 
their incorporation towards their incorporation in drug delivery. Even though SWNT 
dispersion has been achieved with a variety of pharmaceutical solvents, the dispersion 
technique, facilitate reproducible and quantifiable dispersions. Evaluation of SWNT 
dispersions using the methods of microscopy,  Raman spectroscopy to ascertain 
exfoliation of bundles, colloidal dispersion stability (ζ-potential) of the exfoliated bundles 
and a time dependent stability study of SWNT dispersions using pharmaceutical 
excipients established that dispersion in ionic surfactants, such as the dicationic gemini 
surfactant 12-3-12, depends largely on ζ-potential. SWNT dispersion should have a 
uniform dark brown/black coloration, with no visible particulates when examined under a 
light microscope.  
 
5.3  Future Work 
5.3.1 Magnetism  
 To effectively deliver therapeutic molecules across stratum corneum membrane 
as envisaged in our initial model, three main issues will have to be investigated; the 
source of magnetism observed for aggregated SWNTs, and the optimized magnetic field 
strength required to effectively penetrating the intact membrane.  
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5.3.2 Purity of SWNT 
Haven qualitatively established the presence of metallic impurities in SWNT samples, it 
is essential that the quantitative amounts of these impurities be established to enable the 
establishment of limits for quantified impurities within a sample. To this end, the 
following can be investigated; 
i. The quantitative determination of the carbonaceous impurities by TGA 
ii. The quantitative evaluation of metallic impurity concentration in SWNT samples 
 
5.3.3 Dispersion and Characterization 
 The dispersion results presented in this thesis clearly the efficient dispersion of 
SWNTs in selected pharmaceutical solvents/surfactants.  
Considering the promise of gemini surfactants, the relation between surfactant 
concentration, and the dispersion efficiency is not clear. Further information, possibly 
leading to a better understanding of the factors controlling dispersion can be achieved by; 
i. Establishing the minimum concentration of gemini surfactants investigated 
required to produce a stable dispersion, for all gemini surfactants investigated, and 
ii.   Establish if the minimum amount of gemini surfactant required for dispersion is a 
factor of SWNT purity 
For the non-ionic surfactants, it is essential to investigate the relation between the HLB 
values, and the respective molecular weights of the surfactants. This will also include a  
i. Comparison of the dispersion efficiency of at least six surfactants within the same 
family of surfactants with different MW and HLB values (pluronics and 
poloxamers), and  
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ii. Investigate the effect HLB values for mixed dispersing solvents on dispersion 
efficiency (HLB values from 4-20). 
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APPENDICES 
 
APPENDIX  A - COLLATED PROPERTIES OF CARBON NANOTUBES 
FROM SUPPLIERS 
  
A1. NA-SWNT/N&A-SWNT - Single walled carbon nanotubes (described as 90 % 
regular SWNT, Stock#: 1284YJ) is the highest purity of the three non-functionalized 
SWNT samples from Nanostructured & Amorphous Materials, Inc.  
Purchased: July 2007 
Synthesis – Chemical Vapour Deposition 
Parameter Value Method 
Diameter (Outer) 1.1 nm TEM 
Length  5-30 µm TEM 
Purity* 90 % SWNT / 95 % MWNT ▓ 
Amorphous Carbon  ▓ ▓ 
Metal Content (wt %) 3 % i.e. inferred from data EDS 
Ash  ▓ ▓ 
Specific Surface Area  400 m2/g ▓ 
Density at 20 oC 1.7 – 1.9 g/cm3 ▓ 
Melting point/Melting range 3652-3697 ° C (subl/vac) ▓ 
Solubility Insoluble in water ▓ 
 
Elemental Analysis by energy dispersive spectroscopy (EDS). 
 
Components  Contents (%)  
C                   96.30  
Al  0.08  
Cl  0.41  
Co  2.91  
S  0.29  
 
 
  
A2. AP-SWNT are single walled carbon nanotubes (described as 90 % regular SWNT, 
Batch#AP-155). The SWNT were synthesized by electric arc discharge, using Ni/Y 
catalysts. AP-SWNT is reported to be the highest purity as-produced SWNT (i.e. without 
further purification) using the electric arc method. 
Purchased : May 2005 
Synthesis – Electric arc discharge 
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Parameter Value Method 
Diameter# 1.4 nm ▓ 
Length  0.5-3µm ▓ 
Purity* 40-60 %  Near Infrared (NIR) 
Amorphous Carbon  ▓ ▓ 
Metal Content (wt %) 30 % ▓ 
Ash  ▓ ▓ 
Specific Surface Area  ▓ ▓ 
Density 1.2 to 1.5 g/cm3 ▓ 
Bundle Length 1-5µm ▓ 
Bundle Diameter 2-10nm ▓ 
# Diameter does not specify whether internal or external diameter 
* Carbonaceous purity  
Elemental Analysis 
Stated that Ni/Y used as catalyst in synthesis.  
  
A3. P2-SWNT - Single walled carbon nanotubes identified as P2-SWNT from Carbon 
Solutions Inc (P2-SWNT, Batch#02-254). These are described as purified (from AP-
SWNT) SWNT by air oxidation, resulting in high purity SWNT, with reduced residual 
metal (catalyst) content. The purified material closely approximates the pristine state with 
low functionality and low chemical doping. Dispersibility is similar to that of the AP-
SWNTs. 
Purchased : July 2007 
Synthesis – Electric arc discharge 
Parameter Value Method 
Diameter 1.4 nm ▓ 
Length  0.5-1.5 µm ▓ 
Purity* 70-90 %  Near Infrared (NIR) 
Amorphous Carbon  N/A ▓ 
Metal Content (wt %) 7-10 % TGA 
Ash  ▓ ▓ 
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Specific Surface Area  ▓ ▓ 
Density 1.2 to 1.5 g/cm3 ▓ 
Bundle Length 500nm-1.5µm (~1.0µm) ▓ 
Bundle Diameter 4-5nm ▓ 
* Carbonaceous purity  
 
Elemental Analysis 
Stated that Ni/Y used as catalyst in synthesis 
Samples are purified by air oxidation and subsequently treated to remove the catalyst. 
The purified material closely approximates the pristine state with low functionality. 
  
A4. P3-SWNT are acid purified samples of AP-SWNT (Carbon Solutions Inc. Acid 
(nitric acid) purification results in a 3-6 % residual carboxylic acid groups on the tips and 
sidewalls, making the resultant P3-SWNT soluble in water.  
Purchased : July 2005 
Synthesis – Electric arc discharge 
Parameter Value Method 
External Diameter 1.4 nm ▓ 
Length  0.5-1.5 µm ▓ 
Purity* 80-90 %  Near Infrared (NIR)  
Amorphous Carbon  ▓ ▓ 
Metal Content (wt %) 5-10 % TGA 
Ash  ▓ ▓ 
Specific Surface Area  ▓ ▓ 
Density ▓ ▓ 
Bundle Length 500nm-1.5µm (~1.0µm) ▓ 
Bundle Diameter 4-5nm ▓ 
* Carbonaceous purity  
Elemental Analysis 
Stated that Ni/Y used as catalyst in synthesis 
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A5. HMS-SWNT are single walled carbon nanotubes described as high-purity single 
wall carbon nanotubes (Part No: SWNT-12900002-00, Lot No: BSCA 06310069) from 
Helix Material Solutions, Inc. 
Purchased : July 2007 
Synthesis – Chemical Vapour Deposition 
Parameter Value Method 
External Diameter ~ 1.3 nm TEM, Raman 
Length  0.5 ~ 40 µm TEM, SEM 
Purity > 90%  TGA, SEM 
Amorphous Carbon  < 5%  TGA 
Ash  < 2 wt%  TGA 
Specific Surface Area  300 – 600 m2/g  BET 
 
Samples were accompanied by an elemental analysis data sheet (described as spec sheet), 
listing the above methods used in determining the corresponding parameter. This also 
includes a Raman spectrum confirming the presence of the RBM, D and G-bands.  
   
A6.  CT-SWNT - Single walled carbon nanotubes described as high-purity (>90 %) 
single wall carbon nanotubes from Cheap Tubes Inc. These are now listed on the 
supplier’s website as SWNT 90s (http://www.cheaptubesinc.com/SWNTs).    
Purchased: June 2005 
Synthesis – Chemical Vapour Deposition 
 
Parameter Value Method 
External Diameter 1-2 nm / 0.8-1.6nm TEM, Raman 
Length  5-30 SEM 
Purity* > 90 wt % NA 
Amorphous Carbon  NA NA 
Metal Content (wt %) 3 % (inferred from EDS analysis) EDS 
Ash  1.5 wt % TEM 
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Specific Surface Area  407 m2/g TEM 
Density at 20 oC ~ 2.1 g/cm³ TEM, Raman 
* Carbonaceous purity  
 
Reported elemental analysis by EDS 
Components  Contents (%)  
C                   96.32  
Al  0.08  
Cl  0.40  
Co  2.90  
S  0.29  
Samples were accompanied by an elemental analysis data sheet, TEM image, as well as a 
Raman spectrum to confirm the presence of the RBM, D and G-bands.  
   
CNT Handling and Toxicity Information-Summary 
The following information is extracted from the MSDS sheets for Nanostructured & 
Amorphous Materials Inc (N&A) and Cheap Tubes Inc, and Helix Materials Solutions 
Inc. These are generic for both SWNT and MWNT. As the toxicity of these materials has 
not been clearly identified, the exposure limits quoted by both N&A and CheapTubes are 
the values used for graphite exposure.  
 
General protective and hygienic measures The usual precautionary measures for 
handling chemicals should be followed. Keep away from foodstuffs, beverages and feed. 
Remove all soiled and contaminated clothing immediately. Wash hands before breaks 
and at the end of work. Avoid contact with the eyes. Avoid contact with the eyes and 
skin.  
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Additional information about design of technical systems: Properly operating 
chemical fume hood designed for hazardous chemicals and having an average face 
velocity of at least 100 feet per minute.  
 
Breathing equipment: Use suitable respirator when high concentrations are present.  
• Protection of hands: Impervious gloves  
• Eye protection: Safety glasses  
 
Toxicity 
- Acute toxicity 
 
Note: The toxicity of CNTs are classified as acute as a precautionary measure as the 
toxicity is not fully known. There is as yet, no classification data on their carcinogenic 
properties available from the regulatory bodies such as EPA, IARC, NTP, OSHA or 
ACGIH.   
Hazards identification  
• Hazard description: Xi Irritant  
• Information pertaining to particular dangers for man and environment R 36/37 
Irritating to eyes and respiratory system.  
 
Information for safe handling:  
Keep container tightly sealed. 
Store in cool, dry place in tightly closed containers.  
Ensure good ventilation at the workplace.  
Do not store together with strong oxidizing agents  
 
Protection of hands: Impervious gloves  
• Eye protection: Safety glasses  
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Appendix B – EDX Analysis of CNT samples 
 
B1. EDS backscattering image of AP-SWNT: Ni and Y as particles (0.5 to 1 
micrometer), carbon mass with Ni and Y. No distinguishable particles within mass. These 
are reported to contain 40-60 % SWNT and 30 % residual catalyst of Ni/Y catalyst. 
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B2  EDS backscattering image of N&A-SWNT:  A piece of Si as individual shard, Al-
Si as particles (<1 μm), Cr-Fe-Co as particles (100-500 nanometers) and Fe-Cr-Mo (100-
200 nanometers). Carbon mass has trace amounts of Co, Fe, Cl, S, Al. 
The accompanying elemental analysis (in certificate of analysis) indicates the sample 
consists of 96.30 % C, 0.08 % Al, 0.41 % Cl, 2.91 % Co and 0.29 % S. The presence of 
Ni For the purity of SWNT samples, a quote of the carbon content is of little significance; 
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this includes all other allotropes of carbon. The results do show the presence of all the 
listed elements, and additionally, Fe and Si were found in the sample as well.  
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B3  EDS backscattering image of HMS-SWNT Fe-minor Co as particle (10 μm), 
Carbon mass has trace amounts of Fe, S, Si. In the material analysis data sheet 
accompanying the SWNT, the purity has been quoted as >90 %, with < 5% amorphous 
carbon, and < 2 % ash. There is no information as to the possible existence of metallic 
impurities in the sample, contrary to our finding. The presence of metallic impurities can 
be accounted for in the reported CVD synthetic method used to produce these CNTs. 
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B4 EDS backscattering image of CT1-SWNT:   Fe with minor Cr as particle (< 1 
micrometer), Fe-Cr with minor Ca, S, Ti as particle (<1 micrometer), Si as particle (1-2 
micrometers) Carbon mass contains trace amounts of Fe, Cr, Ca, Cl, S, Si. 
The accompanying elemental analysis (in certificate of analysis) indicates the sample 
consists of 96.32 % C, 0.08 % Al, 0.40 % Cl, 2.90 % Co and 0.29 % S. For the purity of 
SWNT samples, a quote of the carbon content is of little significance; this includes all other 
allotropes of carbon.  
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The results do show the presence of all the listed elements, and additionally, Fe and Si 
were found in the sample as well.  
 
B5  EDS backscattering image of CT2-SWNT:   Si as particle (1-2 μm), Fe-Cr with 
minor S, Si, Al as particle (< 1 micrometer). The carbon mass contain trace amounts of 
Fe and S. This sample is similar to CT1-SWNT, except the two are from different 
batches. 
The accompanying elemental analysis (in certificate of analysis) indicates the sample 
consists of 96.32 % C, 0.08 % Al, 0.40 % Cl, 2.90 % Co and 0.29 % S. For the purity of 
SWNT samples, a quote of the carbon content is of little significance; this includes all 
other allotropes of carbon.  
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The spot appears to be heavily contaminated albeight in trace quantities (Mg, Si, P, Cr, 
Fe, Mg, Cr,  Ti, K), together with Fe, Cr and Ni.  
 
B6  EDS backscattering image of P2-SWNT: Ni as particle (100-300 nm). Carbon 
mass contains minor Ni, Cl, S, Si, Y. These are reported to contain 70-90 % SWNT and 
7-10 % residual catalysts from Ni/Y, with low functionality.  
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The results indicate the presence of additional impurities; Cl, S and Si.  
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APPENDIX C – HARVESTING HUMAN STRATUM CORNEUM 
 
The stratum corneum was prepared from trimmed (removing the excess underlying 
subcutaneous tissue) excised human breast tissue by the trypsin technique. Pieces of the 
intact skin (with residual subcutaneous tissue removed) were cut into 4 x 4 cm2, and 
placed in a tissue culture plate, with the stratum corneum facing upwards. Enough trypsin 
(1 % w/v in water) solution was added to completely submerge the skin and incubated 
overnight at 37 oC. The detached SC with detached epidermal layer was placed on a flat 
surface, smoothed out, and the digested epidermis removed by gentle rubbing with 
moistened cotton tipped applicators. The now transparent SC sheets were rinsed with 
water. 
 
 
 
 
